Skip to Content
Your browser is out of date. To use this website, please update your browser or use a different device.
U.S. flag

An official website of the United States government

Durham VA Pharmacy Residency Programs

Durham VA Health Care System welcomes you to the Pharmacy Residency Program

Durham VA Health Care System - Medical Center

The Durham VA Health Care System (DVAHCS) - Medical Center is a 271-bed tertiary care referral, teaching and research facility affiliated with Campbell University College of Pharmacy and Health Sciences, the University of North Carolina Eshelman School of Pharmacy, and the Duke University School of Medicine. The Medical Center provides general and specialty medical, surgical, psychiatric inpatient and ambulatory services, and serves as a major referral center for North Carolina, southern Virginia, northern South Carolina, and eastern Tennessee.

Special programs at Durham include a comprehensive Women’s Health Center, a Home Based Primary Care program, a Geriatric Research, Education, and Clinical Center (GRECC), the VISN 6 Mental Illness, Research, Education, and Clinical Center (MIRECC), the Center for Health Services Research in Primary Care, the Southeast Epilepsy Center of Excellence, and the Epidemiology Research and Information Center (ERIC).

Pharmacy Department Highlights

Pharmacy Residents at the Durham VA will practice under the guidance of a department of over 100 staff members with a team of 42 Clinical Pharmacy Specialists (CPS). The department provides 24 hour centralized services in addition to clinical support provided by our CPS team. The CPS provide progressive, multi-disciplinary, patient-centered care in a wide variety of clinical areas under a scope of practice that grants prescriptive privileges. In addition to their clinical responsibilities, many of our residency program preceptors also serve as preceptors for the regional schools of pharmacy, conduct clinical research projects, participate in scholarly activities, and serve as leaders for numerous state and national pharmacy organizations. The department also offers a VA Learning Opportunities Residency (VALOR) program for pharmacy students.

Beyond the traditional learning experiences of a residency program, our residents will also have the opportunity to participate in teaching certificate programs, co-precept pharmacy students on experiential rotations, and serve as a teaching assistant for a clinical practice lab at UNC. Residents will also receive support and guidance from the Residency Program Director, the Residency Advisory Committee, the Research Advisory Committee, and a formal mentorship program.

The Durham VA Pharmacy Residency programs will utilize the Pharmacy Online Centralized Application Service (PhORCAS) for processing all applications. For more information: www.ashp.org/phorcas

Requirements:

  • Application
  • Letter of intent
  • Curriculum vitae
  • Professional transcripts
  • PhORCAS recommendation form from three references

Due:   

  • PGY1: January 1, 2022
  • PGY2: January 3, 2022 (all PGY2 programs)

 [PMJD1]Link to self reflection questions document

 

Welcome to the Durham VA Health Care System's Pharmacy Residency Program!

2020-2021 Pharmacy Residents

PGY1:

Lorna Doucette, PharmD, MPH is a PGY1 Pharmacy Practice Resident. She received her Doctor of Pharmacy degree from UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. Lorna’s practice interests include ambulatory care and geriatrics. She hopes to pursue PGY2 residency training in one of these areas of interest. Her long-term goal is to practice as a board-certified clinical pharmacist and to serve as a preceptor within the VA system. Contact information: Lorna.Doucette@va.gov  

Taylor Elliott, PharmD, MPH is a PGY1 Pharmacy Practice Resident. She received her PharmD and MPH from the University of Kentucky in Lexington, Kentucky. Taylor’s practice interests include oncology and ambulatory care. Upon completion of her residency, she plans to pursue a PGY2 in an area of interest. Long-term, Taylor hopes to practice as a board-certified clinical pharmacy specialist and actively participate in research. Contact information: Taylor.Elliott@va.gov

PGY2 – Ambulatory Care:

Alec Gates, PharmD is a PGY2 Ambulatory Care Pharmacy Resident. He received his Doctor of Pharmacy Degree from the University of Iowa College of Pharmacy in Iowa City, Iowa and completed his PGY1 pharmacy practice residency at the Omaha VA Medical Center in Nebraska. Alec’s pharmacy practice interests include primary care, geriatrics, and polypharmacy. Upon completion of residency, he hopes to obtain a clinical pharmacy specialist position in an outpatient setting and remain within the VA healthcare system. Contact information: Alec.Gates@va.gov

PGY2 - Geriatrics:

Courtney Burgazli, PharmD is a PGY2 Geriatric Pharmacy Resident. She received her Doctor of Pharmacy degree from West Virginia University School of Pharmacy in Morgantown, WV and completed her PGY1 pharmacy residency at VA Connecticut Healthcare System. Courtney's pharmacy practice interests include geriatrics, ambulatory care, and academia. Upon completion of residency, Courtney hopes to become board certified in geriatrics, and obtain a clinical pharmacy specialist position in the VA. Contact information: Courtney.Burgazli@va.gov 

Krishna Rana, PharmD is a PGY2 Geriatric Pharmacy Resident. He received his Doctor of Pharmacy degree from UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina and completed his PGY1 pharmacy practice residency at the Durham VA Health Care System.

Krishna’s practice interests include ambulatory care and geriatrics. Upon completion of residency, he hopes to obtain a clinical pharmacy specialist position while remaining within the VA system. Contact information: Krishna.Rana@va.gov

PGY2 – Medication-Use Safety and Policy 

Adriana Rhodes, PharmD, MBA is a PGY2 Medication-Use Safety and Policy (MUSP) Pharmacy Resident. She earned her bachelor degree in Biological Sciences from the University of South Carolina. She later received her PharmD and MBA from Palm Beach Atlantic University in West Palm Beach Florida. After graduation Dr. Rhodes completed her PGY1 at the Miami VA Healthcare System. Her practice areas of interest include medication-use policy, mediation safety, and pharmacy administration. Upon completion of residency, Dr. Rhodes hopes to pursue a career in hospital administration. Contact information: Adriana.Rhodes@va.gov 

PGY2 - Oncology:

Jinah Han, PharmD is a PGY2 Oncology Pharmacy Resident. She received his Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill, North Carolina. She completed her PGY1 pharmacy practice residency at the Durham VA Health Care System in Durham, NC. Her interests include ambulatory oncology in geriatric populations. Upon completion of her residency, she hopes to obtain an oncology clinical pharmacy practitioner position while remaining within the VA system. Contact information: Jinah.Han@va.gov

Program Description

The ASHP Accredited PGY1 Residency at the Durham VAMC offers a rewarding and challenging experience designed to refine skills necessary to become an independent practitioner. With this residency, the Resident will have the opportunity to become an integral member of the healthcare system to provide complete and detailed pharmacotherapeutic interventions to improve patient care services. As a member of this healthcare team, the Resident will work in a multi-disciplinary environment that provides active learning, instruction, mentoring and evaluation to develop and enhance pharmaceutical care.

Goals and Objectives

The purpose of the PGY1 Residency Program is to build on Doctor of Pharmacy (PharmD) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.  The program will do this by providing opportunities for the Resident to enhance his/her knowledge, skills, and abilities to effectively provide pharmaceutical care services in many different patient care environments. In addition, the Resident will improve his/her communication skills with other healthcare providers and patients, strengthen drug information skills, learn to promote cost effective drug therapy, and nurture a commitment to lifelong learning.

Practice Areas Required Rotations:

  • Ambulatory Care
  • Internal Medicine (2 months)
  • Geriatrics
  • Pharmacy Administration
  • Drug Information (longitudinal)
  • Anticoagulation (longitudinal)
  • Inpatient Staffing (longitudinal)
  • Psychiatry

 Elective Rotations: (choice of 5)

  • Ambulatory Care (multiple options)
  • Anticoagulation
  • Cardiology
  • Drug Information
  • Emergency Medicine
  • Endocrinology
  • Formulary Management
  • Geriatric Specialty
  • Home Based Primary Care
  • Infectious Diseases
  • Internal Medicine
  • Oncology
  • Pulmonary
  • Psychiatry

Additional Activities

  • Complete and present a residency research project to peers at the UNC Research in Education and Practice Symposium
  • Present a professional poster at the ASHP Midyear Clinical Meeting
  • Prepare a manuscript suitable for publication
  • Teaching opportunities including course instructor, and CE presentations
  • Teaching certificate with UNC Eshelman School of Pharmacy
  • Participation in the Clinical Conference Educational Series
  • Complete a MUE
  • Evaluate and present ADR reports
  • Attend P&T meetings

Accreditation

The Residency Program was originally accredited by ASHP as a pharmacy practice residency in 1994. The program has been reaccredited since then, most recently in 2017, receiving an 8-year accreditation.

Contact Information for PGY1 Program:

Debra W. Kemp, PharmD, BCPS, BCACP
PGY1 Residency Program Director
Clinical Pharmacy Specialist, Ambulatory Care
Durham VA Medical Center
508 Fulton St. (119)
Durham, NC 27705
919-286-0411 ext. 176176
debra.kemp@va.gov

Program Description  

The Durham VA Health Care System (DVAHCS) PGY2 Ambulatory Care Pharmacy Residency Program is designed to develop a healthcare practitioner with advanced skills to support a specialized practice in the care of ambulatory patients. The practice sites deliver care to veterans following the PACT (patient-aligned care team) model which is a patient-driven, team-based approach that delivers efficient, comprehensive, and continuous care through active communication and coordination of resources. The PACT model places the veteran at the center of the care team. The care team also includes their family members, caregivers, and health care professionals—primary care provider, nurse care manager, clinical associate, and administrative clerk. When additional services are needed to meet the veteran's goals and needs, additional team members may be called in for support. These may include social workers, dietitians, pharmacists, mental health practitioners, specialists, and other non-VA health care professionals. The role of the clinical pharmacy specialist on each team is to design, implement, and monitor therapeutic drug plans to improve patient outcomes through direct interactions with patients and interdisciplinary healthcare team members. The residency program will build upon the competencies and experience acquired in a PGY1 residency and promote the development of proficient, independent clinicians with an expertise in ambulatory care pharmacotherapy. Graduates of the program will develop in-depth knowledge of primary care disease states and the therapies used to treat them. Additionally, upon completion of the PGY2 program, the resident should possess competencies that enable attainment of board certification in ambulatory care.

PGY2 Program Purpose  

PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.  

The Residency Experience  

The DVAHCS is comprised of the Durham VA Medical Center (VAMC), Blind Rehabilitation Outpatient Clinic, Brier Creek Dialysis Clinic, Clayton-East Raleigh Community-Based Outpatient Clinic (CBOC), Greenville Health Care Center, Hillandale Road Clinic I, Hillandale Road Clinic II, Morehead City CBOC, Raleigh I CBOC, Raleigh II CBOC, and Raleigh III CBOC. Residents in the PGY2 Ambulatory Care Pharmacy Residency Program will have the opportunity to provide direct patient care at the Raleigh I CBOC, Raleigh III CBOC, Durham VAMC, and Hillandale Road Clinic I. The rotation schedule is developed at the beginning of the residency year based on the resident’s interests and career goals. The residency will begin on July 1 and end on June 30. The first month of the residency will be designed to orient the resident to the DVAHCS and to provide training for the staffing component of the residency. The resident will be introduced to the clinical team through topic presentations and will participate in pharmacy practice management discussions initially and through application of longitudinal experiences. The resident will complete all required rotations, one 1-month elective, and one 3-month elective block to allow for continuity in specialty care. The resident will choose 4-6 specialty learning experiences and spend ½ to 2 days per week in each area for 3 months. Additionally, the resident will have one project month dedicated to their research project and other scholarly activities. Schedules may be tailored throughout the year to meet the resident’s professional goals.

Required Learning Experiences  

Adverse Drug Event Reporting (3 months, ~40 Hours)
PACT I (3 months) 
PACT II (3 months)
Residency Research Project (12 months)
Staffing (12 months, ~5 weekends per year under dual appointment)
 

Elective Learning Experiences

1-Month Electives  

Cardiology
Emergency Medicine
Geriatrics 
Hematology/Oncology 
Internal Medicine 
Medical Writing   
Mental Health     

3-Month Electives

Anticoagulation
Endocrinology
Home-Based Primary Care
PACT Population Management
Pain
Pharmacogenomics
Pulmonology
Women’s Health 

Additional Activities

Additional rotations outside of the above-mentioned will be authorized on a case-by-case basis based on the learning opportunity, including potential Duke and/or UNC affiliated experiences.

Teaching Responsibilities

The resident is expected to assist with precepting PharmD students during during PACT I. The resident may also serve as an instructor in the Pharmacy Skills Laboratory or similiar course at the UNC Eshelman School of Pharmacy during the fall semester, when available.

Conferences and Educational Opportunities

A variety of educational opportunities are available throughout the year to enhance the resident’s knowledge base and foster relationships within the professional community. The resident is expected to attend scheduled conferences, seminars, and workshops throughout the year.

     ASHP Midyear Clinical Meeting
     Pharmacy Grand Rounds
     Quarterly Professional Development and Leadership Series
     Residency Clinical Conference
     UNC Research in Education and Practice Symposium
     VA Pharmacy Residents Conference Call Series

Accreditation Status 

The PGY2 Ambulatory Care Pharmacy Residency Program was founded in 2019, has been ASHP-accredited since 2019, and received an 8-year accreditation in 2021.     

Residency Director and Contact Information 

Lindsay Garris, PharmD, BCPS, BCACP
PGY2 Ambulatory Care Pharmacy Residency Program Director
Raleigh III VA Community-Based Outpatient Clinic
2600 Atlantic Ave, Suite 200
Raleigh, NC 27604
Phone: 919-755-2620 ext. 162748
E-mail: Lindsay.Garris@va.gov

Program Description

The ASHP-Accredited Postgraduate Year Two (PGY2) Geriatrics Residency Program at the Durham VA Health Care System (DVAHCS) has been developed in cooperation with the Duke Center for the Study of Aging and Human Development and the Durham Geriatric Research Education and Clinical Center (GRECC). The residents will work with experienced clinicians, educators and researchers from Campbell University College of Pharmacy and Health Sciences, University of North Carolina (UNC) Eshelman School of Pharmacy, and Duke University School of Medicine. The residency provides trainees experiences in practice areas across the continuum of care including long term care (LTC), ambulatory care, home based care, and hospital settings. Interested DVAHCS PGY1 residents may apply for early commitment into the program.

PGY2 Program Purpose

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification.

Practice Settings

The primary practice settings of this residency program include LTC in the DVAHCS Community Living Center (CLC) and Ambulatory Care in the Geriatric Patient Aligned Care Team (PACT). The CLC is a VA LTC facility that offers long term care, rehabilitation, respite care, and hospice/palliative care services to our nation’s Veterans. Geriatric PACT offers enhanced ambulatory care and interdisciplinary expertise for managing community-dwelling Veterans with challenging healthcare needs due to multiple chronic diseases, coexisting cognitive and functional decline, and psychosocial factors. The resident’s rotation schedule is developed at the beginning of the residency year based on the interests and career goals of each resident. Schedules may be tailored throughout the year based on resident’s professional goals.

Required Learning Experiences

CLC Short Stay and Rehab I and II (2 months) 
LTC CLC Monthly Pharmacy Assessments I and II (12 months total) 
Models of Care (1 month) 
Geriatric PACT I and II (12 months total) 
Geriatric Pharmacotherapy and Professional Development (12 months) 
Geriatric Psychiatry (1 month) 
Home Based Primary Care-HBPC (1 month) 
Hospice and Palliative Care (1 month) 
Orientation (1 month) 
Medical Writing (12 weeks) 
Research Project (12 months) 
Adverse Drug Reaction Reporting (12 weeks) 
Staffing (12 months, ~5 weekends per year under dual appointment) 
 

Elective Rotational Experiences   
*All rotations have a one (1) month duration

• 
Senior PharmAssist 
• Ambulatory Care 
• Cardiology                                                   
• Emergency Medicine                                     
• Endocrinology                                               
• Pharmacy Administration                               
• Infectious Disease                                       
• Internal Medicine                                          
• Oncology                                                     
• Pain Management                                         
• Pharmacogenomics                                       
• Pulmonary                                                    

                    

Additional Learning Experiences

Additional rotations outside of the above-mentioned will be authorized on a case-by-case basis based on the learning opportunity, including potential Duke and/or UNC affiliated experiences

Teaching Responsibilities

The resident is expected to assist with precepting PGY1 residents on their geriatric clinical rotation. The resident may also serve as an instructor in the Pharmacy Skills Laboratory at the UNC Eshelman School of Pharmacy during the fall semester, when available. The resident will assist in teaching Duke University School of Medicine geriatric medicine fellows’ principles of geriatric pharmacotherapy and have numerous teaching opportunities incorporated within rotational experiences.

Geriatric Conferences and Education Opportunities

A variety of geriatric educational opportunities are available through Duke Center for the Study of Aging and Human Development and the DVAHCS GRECC to enhance the resident’s geriatric knowledge base and foster professional relationships within the geriatric professional community. The resident is expected to attend scheduled conferences, seminars, and workshops, as permitted, during the year.

Select Geriatric Conferences and Education Opportunities

  • Pharmacy Clinical Conference
  • Geriatric Grand Rounds
  • Geriatric Friday Morning Conference
  • Geriatrics Excellence in Teaching Series
  • Geriatric Core Curriculum
  • Geriatric Evidence Based Medicine Course
  • Advance Course in Long Term Care Series

Accreditation Status

The PGY2 Geriatric Pharmacy Residency Program was originally accredited in 1993. The program has been continually re-accredited since the, most recently in 2017, and has a full 8-year accreditation from ASHP. 

Residency Director and Contact Information

Marc Pepin, PharmD, BCPS, BCGP
Director, PGY-2 Geriatrics Pharmacy Residency Program
Durham VA Health Care System - Medical Center
508 Fulton Street (119)
Durham, NC 27705
Phone: 919-286-0411 ext. 174274
E-mail: marc.pepin@va.gov

Welcome to the Durham VA PGY2 Medication Use Safety and Policy Residency Program

Program Description

The ASHP-Accredited Postgraduate Year Two (PGY2) Medication Use Safety and Policy Residency Program at the Durham Veterans Affairs Health Care System (DVAHCS) is designed to develop a health care practitioner with advanced skills in the practice of medication use policy, medication safety, drug information, literature evaluation, medical writing and editing, teaching and education, clinical problem solving, and project management skills.  The Medication Use Safety and Policy Program will build upon the competencies and experience acquired in the PGY1 residency and will be flexible to accommodate the interests and goals of the resident. Graduates of the program will be prepared for a variety of activities including medical writing, developing evidence-based materials, presenting in a variety of settings including small group and didactic lectures, leading medication policy development, managing drug shortages, and planning educational experiences for students and residents on rotation in drug information.  Additionally, upon completion of the PGY2 program, the resident should possess competencies that enable attainment of board certification or further credentials.
 

Program Purpose:

The purpose of this PGY2 pharmacy residency program is to build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
 

Site Description 

The residency is hospital-based and includes formalized learning experiences with the site’s centralized Formulary Management/Pharmacoeconomic team, in the Drug Information Center (DIC), and with various clinical pharmacist specialists within the organization. The Formulary Management team is composed of three dedicated clinical pharmacists that support the Pharmacy Service through involvement in quality improvement and medication use policy development by facilitating medication safety and cost-savings programs such as therapeutic interchange and evidence-based use guidelines. The DIC is a comprehensive, hospital-based drug information service that supports drug information requests from the Medical Center’s healthcare providers. The DIC responds to approximately 50-100 requests per year and is also a training site for Advanced Pharmacy Practice Experience (APPE) student rotations and both PGY1 and PGY2 residents.
 

Expected Learning Opportunities:

  • Developing and implementing medication use policies and resources
  • Conducting medication use evaluations and other quality management reviews
  • Assisting in coordination of the Pharmacy and Therapeutics committee
  • Coordinating the adverse drug reaction reporting program
  • Involvement in the provision of drug information services to healthcare professionals
  • Participation in the administrative aspects of maintaining a drug information service
  • Training and precepting pharmacy students and residents
  • Formal lectures and teaching experiences at UNC Eshelman School of Pharmacy and Campbell University College of Pharmacy
  • Completion of a formal resident research project
  • Medical writing, publishing, and peer reviewing
  • Participation in the Investigational Drug Service
  • Involvement with continuous quality improvement initiatives of the Pharmacy Service
  • Optional participation in the teaching certificate program through UNC Eshelman School of Pharmacy

 

Required Rotations:

  • Medication-Use Policy (11 months)
  • Medication Safety (12 months)
  • Drug Information Practice I (12 months)
  • Investigational Drug Service (12 months)
  • Administration (11 months)
  • Medical Writing (3 months)
  • Residency Research Project (12 months)
  • Staffing (11 months, 5 weekends per year under dual appointment)
  • Orientation (1 month)

 

Elective Rotations (up to 3 months): The resident may select from a variety of elective rotations to augment their specific areas of interest. Potential electives may include:

  • Academic Detailing
  • Pharmacogenomics
  • Anticoagulation or other Clinical Practice Rotations
  • Non-VA Medication Use Policy or Medication Safety
  • Additional rotations outside of the VA system will be authorized on a case-by-case basis based on the learning opportunity

Program Benefits

The Veterans Health Administration sets annual residency stipends (currently $46,796) and benefits for all VA residency programs. Each resident is offered 13 days each of accrued vacation and sick leave/family care, 10 paid federal holidays, and a health care benefits package. Pharmacy residents are also given educational leave with pay to attend and present at local and national conferences. The resident may also be eligible for a faculty appointment with the UNC Eshelman School of Pharmacy.
 

Eligibility Requirements

Qualified applicants are required to possess a Doctor of Pharmacy degree from an accredited college of pharmacy, be a citizen of the United States, have an active pharmacy license in any state by the first day of the residency, and have completed an accredited Pharmacy Practice or PGY1 Residency training program. An on-site interview is required.

Accreditation Status

The residency program was originally accredited by ASHP as a Drug Information PGY2 Residency Program. This program welcomed its first resident in July 2013 and in 2014, received a full 6-year accreditation cycle from ASHP. In 2020, the residency program transitioned to the ASHP accreditation standards associated with the PGY2 Medication Use Safety and Policy program.

How to Apply:

By January 4, 2021, interested individuals should submit an application through PhORCAS with the following components: 

  1. Letter of intent indicating why advanced training through a medication use policy and safety residency program at the Durham VA is desired
  2. Curriculum vitae
  3. Professional transcripts
  4. PhORCAS recommendation form from three references.  

 

Residency Director Contact Information: 

Jamie N. Brown, PharmD, FCCP, BCPS, BCACP
PGY2 Medication-Use Safety & Policy Residency Program Director
Drug Information/Investigational Drug Service Program Manager
Durham VA Medical Center
508 Fulton St. (119)
Durham, NC 27705
919-286-0411 ext. 176072
jamie.brown2@va.gov

Welcome to the Durham VA Health Care System PGY2 Oncology Program! We hope your time with us is educational, rewarding, and enjoyable.

Program Description

The Durham VA Health Care System (DVAHCS) offers an ASHP-Accredited PGY2 Pharmacy Residency in Oncology. This program will build upon the competencies developed during a PGY1 residency to develop the advanced skills of an Oncology Clinical Specialist . Over twelve months of individualized training, the resident will complete longitudinal as well as traditional block learning experiences focused on direct patient care, education & research. In addition to clinical experiences, the resident will complete an approved research project and have the opportunity to complete a teaching certificate through our affiliation with the University of North Carolina Eshelman School of Pharmacy. Graduates of the program will display expert level knowledge and skills in the complex practice of oncology. In addition to clinical experiences, the resident will complete an approved research project. Graduates of the program will display expert level knowledge and skills in the complex practice of oncology. They will be prepared to practice in a variety of environments and attain oncology board certification (BCOP).

PGY2 Program Purpose  

PGY2 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.

Practice Settings

The primary practice setting for this residency will be the Hematology Oncology Clinic at the DVAMC. Here, the resident will participate in multidisciplinary clinics with full time VA faculty and staff members as well as faculty and hematology/oncology fellows who practice at the DVAHCS and the Duke Comprehensive Cancer Center. In addition, the resident will participate in, and ultimately lead, Oncology Pharmacist Clinic appointments and will learn to practice under a pharmacist scope of practice that supports prescriptive authority. The resident will work with patients with a variety of malignant diagnoses to ensure provision of optimal medication management and address adherence issues when identified. In addition, the resident will work with the Oncology Consult Service and other Clinical Pharmacy Specialists to ensure evidence-based and patient-centered pharmacotherapy across the continuum of care.

 Required Learning Experiences

Learning experiences are longitudinal unless otherwise noted below.

  • Oncology Clinics
  • Pharmacist Phone and Face to Face Clinic
  • Multidisciplinary Clinics
  • Oncology Formulary Management
  • Oncology Inpatient Consults
  • Practice Management & Professionalism
  • Residency Research Project
  • Oncology Operations
  • Investigational Drug Service
  • Pharmacogenomics
  • Adverse Drug Reaction Reporting Ambulatory Staffing
  • Internal Medicine (4-6 weeks)
  • Hospice & Palliative Care (4-6 weeks)
  • Gynecologic Oncology (2-4 weeks)

Elective Learning Experiences

The resident may select from a variety of elective learning experiences. In addition to the experiences below, additional time may be scheduled in a required area as an elective or additional experiences outside the VA system may be available.

  • Medical Writing (12 weeks)
  • Infectious Diseases (2-4 weeks)
  • Pediatric Hematology/Oncology (2-4 weeks based on availability)
  • Anticoagulation (Block or longitudinal – duration TBD)
    • Phone &/or Face to Face Clinic

Additional Activities

  • Complete an IRB approved residency research project and complete a manuscript suitable for publication. The resident will also submit to present their research project at the Hematology Oncology Pharmacy Association Annual Meeting.
  • Co-precept PharmD candidates and/or PGY1 Residents

Program Stipend and Benefits

The Veterans Health Administration sets annual residency stipends (currently $46,613) and benefits for all VA residency programs. Each resident is offered 13 days each of accrued annual leave and sick/family care leave, 10 paid federal holidays, and a healthcare benefits package. Pharmacy residents are also given educational leave with pay to attend and present at select professional meetings. The resident may also be eligible for a faculty appointment with the UNC Eshelman School of Pharmacy.

Eligibility Requirements

Qualified applicants are required to possess a Doctor of Pharmacy degree from an accredited college of pharmacy, be a citizen of the United States, have an active pharmacy license in any state by the first day of the residency, and have completed an accredited Pharmacy Practice or PGY1 Residency training program.

Application Process

Interested applicants should submit an application through PhORCAS with the following components by January 6, 2020

  • Letter of intent indicating why advanced training in oncology at the Durham VA is desired
  • Curriculum vitae
  • Professional transcripts
  • PhORCAS recommendations from three references.

Residency Director Contact Information:

Julia M. Hammond, PharmD, BCOP
PGY2 Oncology Residency Program Director
Clinical Pharmacy Specialist - Hematology/Oncology
Durham VA Medical Center
508 Fulton St. (119)
Durham, NC 27705
919-286-0411 ext. 172218
Julia.Hammond2@va.gov 

Program Benefits

The Veterans Health Administration sets annual residency stipends (currently $43,196 for PGY1 and $46,991 for PGY2 programs) and benefits for all VA residency programs. Each resident is offered 13 days each of accrued vacation and sick leave/family care, 11 paid federal holidays, and a health care benefits package. Pharmacy residents are also given educational leave with pay to attend and present at local and national conferences. The resident may also be eligible for a faculty appointment with the UNC Eshelman School of Pharmacy.

 

Eligibility Requirements

  • Doctor of Pharmacy degree from an accredited College of Pharmacy or a Bachelor of Pharmacy with equivalent clinical experience
  • Citizen of the United States
  • Pharmacist Licensure/eligibility for licensure in any state in the U.S.
    • PGY1: licensure within 90 days of graduation
    • PGY2: licensure by the first day of the residency
  • Completion of an accredited Pharmacy Practice or PGY1 Residency Program (PGY2 Only)

Select Publications: 

 

2021

  • Bailey AG, Brown JN, Hammond JM. Cryotherapy for the prevention of chemotherapy-induced peripheral neuropathy: a systematic review. J Oncol Pharm Pract. 2021;27:156-64.
  • Bates, J. Education, communication can reduce risks of cannabidiol use among patients with cancer. HemOnc Today, Pharmacology Consult; October 9, 2020. Available at: https://www.healio.com/news/hematology-oncology/20201009/education-communication-can-reduce-risks-of-cannabidiol-use-among-patients-with-cancer
  • Compton ALP, Pepin MJ, Katzenberger DR, Kemp DW, Brown JN. Vitamin D supplementation during statin rechallenge in patients with a history of intolerance [Letter]. Ann Pharmacother. 2021;55:814-5.
  • Dong O, Bates J, Chanfreau-Coffinier C, et al. Veterans Affairs pharmacogenomic testing for veterans (PHASER) clinical program. Pharmacogenomics. 2021;22:137-44.
  • Gessner KH, Jung J, Cook HE, et al. Implementation of postoperative standard opioid prescribing schedules reduces opioid prescriptions without change in patient-reported pain outcomes. Urology. 2020;S0090-4295:31372-9.
  • Lee TH, Chan A, Bryan W, Park L, Hashem M, Townsend M, Moylan C, Britt R, Choi S, Naggie S. Proton pump inhibitor usage reduces sustained viral response rates for veterans with HIV/HCV coinfection on ledipasvir/sofosbuvir: a real-world study from a multicentre VA cohort. J Viral Hepat. 2021;28:630-6.
  • Madaras-Kelly K, Hostler C, Townsend M, et al.  Impact of implementation of the core elements of outpatient antibiotics stewardship within Veterans Health Administration emergency department and primary care clinics on antibiotic prescribing and patient outcomes.  Clin Infect Dis.  2021;73:e1126-34.
  • Mistry VM, Morizio PL, Pepin MJ, Bryan WE, Brown JN. Role of memantine in the prophylactic treatment of episodic migraine: A systematic review. Headache. 2021;61:1207-13.  
  • Morizio PL, Britnell SR, Ottman AA. Impact of national valsartan recalls on veterans’ outcomes. Ther Adv Drug Saf. 2021;12:1-8.
  • Nagavelli H, Mariano E, Krishnamoorthy V, Ray N, Hsia H, Ellis A, Memtsoudis S, Bryan W, Pepin M, et al. Evaluation of trends in continuous peripheral nerve block utilization for total knee arthroplasty within and outside the Veterans Affairs Healthcare System. Reg Anesth Pain Med. 2021 Jun 2. [Online ahead of print].
  • Palmer S, Tillman III F, Sharma P, et al. Safety of intravenous bisphosphonates for the treatment of hypercalcemia in patients with pre-existing renal dysfunction. Annals Pharmacother. 2021;55:303-10.
  • Patel JN, Voora D, Bell G, Bates J, et al. North Carolina’s multi-institutional pharmacogenomics efforts with the NC precision health collaborative. Pharmacogenomics. 2021;22:73-80.
  • Shmuel S, Pate V, Pepin M, Bailey J, et al. Effects of anticholinergic and sedative medication use on fractures: a self-controlled design study. J Am Geriatr Soc. 2021 Jul 22. [Online ahead of print].
  • Shmuel S, Pate V, Pepin M, Bailey J, et al. Quantifying cumulative anticholinergic and sedative drug load among US Medicare beneficiaries. Pharmacoepidemiol Drug Saf. 2021;30:144-56.
  • Smith KR, Kahlon CH, Brown JN, Britt RB. Methylphenidate use in geriatric depression: a systematic review. Int J Geriatr Psychiatry. 2021;36:1304-12.
  • Tuteja S, Salloum R, Elchynski A, Smith DM, Rowe E, Blake K, Limdi N, Aquilante C, Bates J, et al. Multi-site evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy. Clin Transl Sci. 2021. [In press].
  • Wind LS, Knight TG, Auten JJ, Bates JS, et al. Evaluation and optimization of a clinical pharmacist driven transitions of care model for malignant hematology. J Oncol Pharm Pract. 2021;27:283-7.

2020

  • Adams AD, Pepin MJ, Brown JN. Role of suvorexant in the prevention of delirium during acute hospitalization: a systematic review. J Crit Care. 2020;59:1-5.
  • Bates, Jill S. In: DePiro JT, Yee GC, Posey L, Haines ST, Nolin TD, Ellingrod V. eds. The Myelodysplastic Syndromes (chapter e154). Pharmacotherapy: A Pathophysiologic Approach. Eleventh edition. McGraw-Hill.
  • Elias AM, Ogunwale AN, Pepin MJ, Bailey JC, Adams AD, et al. High prevalence of fall-related medication use in older veterans at risk for falls. J Am Geriatr Soc. 2020;68:438-9.
  • Eichenberger EM, Rolfe R, Shoff CJ, Pappas S, Townsend M, Hostler CJ.  Staphylococcus aureus prostatic abscess in the setting of prolonged S. aureus bacteremia.  Case Rep Infect Dis.  2020;2020:7213838.
  • Fares M, Atienza S, Grate LS, Roddy J, Bates JS, et al. Value of cancer care forum: Pharmacy call to action. J Hem Onc Pharm. 2020;10:212-19.
  • Glynn-Servedio, B. In Colin M. Ed. Dementia and usage of N-methyl-D-aspartate receptor antagonists (chapter 36). The Neuroscience of Dementia. Cambridge, MA: Academic Press.
  • Hu AM, Brown JN. Comparative effect of allopurinol and febuxostat on long-term renal outcomes in patients with hyperuricemia and chronic kidney disease: a systematic review. Clin Rheumatol. 2020 May 16. [Epub ahead of print].
  • Lee S, Sneed GT, Brown JN. Treatment of Helicobacter pylori with nitazoxanide-containing regimens: a systematic Review. Infect Dis (Lond). 2020;52:381-90.
  • Lentz KL, Clark SM, Ayarza M, Liu B, Morgan K, Wind L, Hairston A. Evaluation of thiamine for the prevention of ifosfamide-induced encephalopathy. J Oncol Pharm Pract. 2020;26:406-12.
  • McKnight AH, Katzenberger DR, Britnell SR. Colchicine in acute coronary syndrome: a systematic review. Ann Pharmacother. 2020 Jul 13. [Epub ahead of print]
  • McKnight AH, Townsend ML, Hashem MG, Naggie S, Park LP, Britt RB. Standard versus extended duration direct-acting antiviral therapy in hepatitis C patients with slow response to treatment. Ann Pharmacother. 2020;54:1057-64.
  • Melville BL, Bailey J, Moss J, Bryan W, Davagnino J, Twersky J, Pepin M. Description of pharmacist recommendations in the Caring for Older Adults and Caregivers at Home (COACH) program. Sr Care Pharm. 2020;35:38-46.
  • Ohnuma T, Raghunathan K, Ellis A, Whittle J, Pyati S, Bryan W, Pepin M, et al. Effects of acetaminophen, nsaids, gabapentinoids, and their combinations on postoperative pulmonary complications after total hip or knee arthroplasty. Pain Med. 2020 Feb 26. [Epub ahead of print].
  • Ohnuma T, Raghunathan K, Moore S, Setoguchi S, Ellis AR, Fuller M, Whittle J, Pyati S, Bryan WE, Pepin M, et al. Dose-dependent association of gabapentinoids with pulmonary complications in total hip and knee arthroplasties. J Bone Joint Surg Am. 2020;102:221-9.
  • Parker, MH. Primary prevention of cardiovascular disease and public health. In: 2020 ACCP/ASHP Cardiology Pharmacy Preparatory Review and Recertification Course. Lenexa, KS: American College of Clinical Pharmacy, 2020:1-46.
  • Pepin MJ, Valencia W, Bettger J, Pearson M, Manning K, Sloane R, Schmader K, Morey M. Impact of supervised exercise on one-year medication use in older veterans with multiple morbidities. Gerontol Geriatr Med. 2020;6:1-6.
  • Sebring EJ, Rudisill MA, Bates JS, et al. An evaluation of the effect of pharmacist-led comprehensive chemotherapy consultation services on outpatient appointment adherence. J Manage Care Spec Pharm. 2020;26:723-7.
  • Shoff CJ, Townsend ML, Tillekeratne LG, et al. Improved empiric antibiotic prescribing for acute cystitis with use of local urinary antibiogram and clinical decision support system. Infect Control Hosp Epidemiol. 2020;41:1351-3.
  • Shore SN, Britnell SR, Brown JN.  Safety analysis of long-term phenazopyridine use for radiation cystitis.  J Onc Pharm Pract. 2020;26:306-11.
  • Smith KR, Bryan WE, Townsend ML, Randolph AE, Vanderman AJ, Woodard CL, Brown JN. Impact of prophylactic oseltamivir on INR in patients on stable warfarin therapy. J Thromb Thrombolysis. 2020;50:452-6.

2019

  • Bates J, Auten J, Sketch M, et al. Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation. J Oncol Pharm Practice. 2019;25(4):896-902.
  • Brown JN, Gordon S, Jacob S, Tillman III F, Britnell SR. Assessing the economic value of pharmacy resident participation in an investigational drug service. J Pharm Pract. 2019 June 23. [Epub Ahead of Print].
  • Brown JN, Tillman III F, Jacob S, Britnell SR.  Economic outcomes associated with an investigational drug service within a Veterans Affairs health care system.  Contemp Clin Trials Commun.  2019;14:100354.
  • Carrasquillo MA, Vest T, Bates J, et al. A chemotherapy privileging process for advanced practice providers at an academic medical center. J Oncol Pharm Pract. 2019 May 15. [Epub Ahead of Print]. 
  • Chargualaf MJ, Giao TT, Abrahamson AC, Steeb D, Law M, Bates J, et al. Layered learning pharmacy practice model in Ethiopia. J Oncol Pharm Practice. 2019;25:1699-704.
  • Chen Q, Hsia HL, Overman R, Bryan W, Pepin M, et al. Impact of an opioid safety initiative on patients undergoing total knee arthroplasty: A time series analysis. Anesthesiology. 2019;131:369-80.
  • Elias A, Pepin MJ, Brown JN. Adjunctive memantine for opioid use disorder treatment: a systematic review. J Subst Abuse Treatment. 2019;107:38-43.
  • Henderson W, Friedman D, Parker M. Partners in oncology care: coordinated follicular lymphoma management. Fed Pract. 2019;36:S21-S23.
  • Henderson W, Parker M, Rutherford AL, Hayes BP. A new approach to new physician orientation: Six key components. Fam Pract Manag. 2019;26:24-8.
  • Hunt CM, Turner MJ, Gifford EJ, Britt RB, Su GL. Identifying and treating non-alcoholic fatty liver disease. Federal Practitioner. 2019;36:20-9.
  • Jacob S, Britt RB, Bryan WE, Hashem MG, Hale JC, Brown JN. Economic outcomes associated with safety interventions by a pharmacist-adjudicated prior authorization consult service.  J Manag Care Spec Pharm. 2019;25:411-6.
  • Jacob S, VanDeale MA, Brown JN. Treatment of demodex-associated inflammatory skin conditions: a systematic review. Dermatol Ther. 2019;32:e13103.
  • Karamchandani K, Pyati S, Bryan W, Pepin M, et al. New persistent opioid use after postoperative intensive care in US veterans. JAMA Surg. 2019; 154:778-80.
  • Kuo AC, Raghunathan K, Lartigue AM, Bryan WE 3rd, Pepin MJ, et al. Freedom from opioids after total knee arthroplasty. J Arthroplasty. 2019;34:893-7.
  • Moss J, Bryan W, Wilkerson L, King H, Jackson G, Owenby R, et al. An interdisciplinary academic detailing approach to decrease inappropriate medication prescribing by physician residents for older veterans treated in the emergency department. J Pharm Pract. 2019;32:167-74.
  • Naylor JC, Wagner HR, Johnston C, et al. Pain intensity and pain interference in male and female Iraq/Afghanistan-era veterans.  Womens Health Issues. 2019;29(Suppl 1):S24-S31.
  • Ohnuma T, Krishnamoorthy V, Ellis AR, Yan R, Ray ND, Hsia HL, Pyati S, Stefan M, Bryan WE, Pepin MJ, et al. Association between gabapentinoids on the day of colorectal surgery and adverse postoperative respiratory outcomes. Ann Surg. 2019. 270:e65-7.
  • Ottman AA, Townsend ML, Hashem MG, Britt RB. Impact of substance use disorder on the rate of sustained virological response in veterans with chronic hepatitis C treated with direct-acting antivirals. Ann Pharmacother. 2019;53:581-7.
  • Parker MH. Primary prevention of cardiovascular disease and public health. In ACCP/ASHP Cardiology Pharmacy Preparatory Review and Recertification Course, 2019 ed. Lenexa,KS: American College of Clinical Pharmacy, 2019: 1-44.
  • Phillips J, Hanrahan C, Brown JN, May D, Britnell SR, Ficzere C. Guiding principles for evaluating tertiary health care resources: The A2C2QUIRE framework. J Am Coll Clin Pharm. 2019;3:485-93.
  • Raghunathan K, Ray N, Bryan W, Pepin M, et al. Trends in chronic opioid use around inpatient surgery within the Veterans Health Administration. JAMA Surg. 2019; 154:1158-9.
  • Robinson JM, Renfro CP, Shockley SJ, Blalock SJ, Watkins AK, Ferreri SP. Training and toolkit resources to support implementation of a community pharmacy fall prevention service. Pharmacy (Basel). 2019;7:113.
  • Schepers A, Jones A, Reeves B, Tuchman S, Bates J. A comparison of response in the presence or absence of a delay in induction therapy with bortezomib, lenalidomide, and dexamethasone. J Oncol Pharm Pract. 2019;25:1692-8.
  • Sneed GT, Lee S, Brown JN, Hammond JM. The role of pazopanib in non-clear cell renal cell carcinoma: a systematic review. Clin Genitourin Cancer. 2019;17:419-24.

2018

  • Bates J, Fleszar SL, Holle LM, et al. Further defining the scope of hematology/oncology pharmacy practice. Hematology Oncology Pharmacist Association (HOPA) white paper. Available at: http://www.hoparx.org/images/hopa/resource-library/guidelines-standards/HOPA18_Scope-2_Web2.pdf.
  • Bates J. Reflection on personal impact and growth: Using goal setting to achieve more. Hematology Oncology Pharmacy Association Newsletter. 2018;15.
  • Britnell SR, Brown JN, Hashem MG, Hale JC, Bryan WE, Hammond JM, Britt RB.  Post-graduate pharmacy resident involvement in prior authorization drug request adjudication.  Am J Health Syst Pharm. 2018;75(suppl 4): S87-S93.
  • Britnell SR, Chillari KA, Brown JN.  The role of xanthine oxidase inhibitors in patients with history of stroke: a systematic review.  Curr Vasc Pharmacol.  2018;16:583-8.
  • Britt RB, Brown JN.  Characterizing the severe reactions of parenteral vitamin K1.  Clin Appl Thromb Hemost.  2018;24:5-12.
  • DeLucca BJ, Richardson RM, Stewart JT. Melatonin treatment of visual hallucinations in Parkinson disease.  J Clin Psychopharmacol. 2018;38:532-4.
  • Gee ME, Watkins AK, Brown JN, Anastasia EJ.  Ivabradine for the treatment of postural orthostatic tachycardia syndrome: a systematic review.  Am J Cardiovasc Drugs.  2018;18:195-204.
  • Jasmine Bullard A, Cunningham FE, Volpp BD, Lowy E, Beste LA, Heron BB, Geraci M, Hammond JM, et al. Preventing hepatitis B reactivation during anti-CD20 antibody treatment in the Veterans Health Administration. Hepatol Commun. 2018;2:1136-46.
  • Kasarala G, Choi S, Lopez K, Britt RB, Boatright C, Tillmann HL. Curing HCV after organ transplant: increased risk of rejection following HCV elimination. Transpl Infect Dis. 2018;20.
  • Ostroff ML, Aloi K, Bryan WE, Moss JM, Garris LA, Sloane R, Hewitt JH, Thomas C, Bailey JK. Evaluation of hypoglycemia and potential risk factors in a Veterans Affairs community living center. Consult Pharm. 2018;33:37-47.
  • Ottman AA, Townsend ML, Hashem MG, DiMondi VP, Britt RB. Incidence of drug interactions identified by clinical pharmacists in veterans initiating treatment for chronic hepatitis C infection. Ann Pharmacother. 2018;52:763-8.
  • Ottman AA, Warner CB, Brown JN.  The role of mirtazapine in patients with fibromyalgia: a systematic review.  Clin Rheumatol. 2018;38:2217-24.
  • Titus-Rains K, Brown JN, Hammond JM.  Ibrutinib-associated tumor lysis syndrome in chronic lymphocytic leukemia/small lymphocytic lymphoma and mantle cell lymphoma: a case series.  J Oncol Pharm Pract. 2018;24:544-9.
  • Turnigan E, Amerine L, Bates J. Integration of physical assessment in pharmacy practice. Am J Health-Syst Pharm. 2018;75:169-70.
  • Warner CB, Ottman AA, Brown JN.  The role of atomoxetine for Parkinson disease-related executive-dysfunction: a systematic review.  J Clin Psychopharmacol. 2018;38:627-31.
  • Watkins AK, Gee ME, Brown JN.  Efficacy and safety of levetiracetam for migraine prophylaxis: a systematic review.  J Clin Pharm Ther.  2018;43:467-75.

2017

  • Britnell SR, Britt RB, Naggie S. Safety of approved direct acting antiviral regimens: the bridge to access for special populations. In: Mangia A, ed. The Treatment of Hepatitis C – Edizioni Minerva Medica. 1st ed. Torino, Italy: Corso Bramante; 2017: 80-9.
  • Britnell SR, Jackson AD, Brown JN, Capehart BP.  Aripiprazole for post-traumatic stress disorder: a systematic review.  Clin Neuropharmacol.  2017;40:273-8.
  • Bosworth HB, Brown JN, Danus S, Sanders LL, McCant F, Zullig LL, Olsen M.  Evaluation of a packaging approach to improve cholesterol medication adherence.  Am J Manag Care.  2017;23:e280-6.
  • Brown JN, Britnell SR, Stivers AP, Cruz JL.  Medication safety in clinical trials: role of the pharmacist in optimizing practice, collaboration, and education to reduce errors.  Yale J Biol Med. 2017; 90:125-33.
  • Brown JN, Murfin M.  Drug information and electronic resources.  In:  Dong BJ, Elliot DP, eds.  Ambulatory Care Self-Assessment Program, 2017 Book 3.  Nutrition and Gastroenterologic Care.  Lenexa, KS: American College of Clinical Pharmacy, 2017:171-190.
  • Chillari KA, Britnell SR, Brown JN, Hammond JM.  Desensitization to protein kinase inhibitors: a systematic review.  Ann Allergy Asthma Immunol.  2017; 119:9-15.
  • Glynn-Servedio BE, Ranola TS. AChE Inhibitors and NMDA receptor antagonists in advanced alzheimer's disease. Consult Pharm. 2017;32:511-8.
  • Glynn-Servedio B, Lezcano B, Welch L, Kennelty K. Development of a pharmacist-managed telehealth clinic to optimize medication regimens in recently hospitalized rural geriatric Veterans using intervention mapping. J Pharm Soc Wis. 2017; 20:49-53.
  • Loy BM, Yang S, Moss JM, Kemp DW, Brown JN.  Application of the layered learning practice model in an academic medical center.  Hosp Pharm. 2017; 52:266-72.
  • Muzyk AJ, Peedin E, Lipetzky J, Parker H, McEachern MP, Thomas K. Substance use education in United States schools of pharmacy: a systematic review of the literature. Subst Abus. 2017; 12:1-9.
  • Naples JG, Mantovani EH, Rothrock-Christian T, Brown JN.  Assessment of postgraduate year two pharmacy residency programs within the Veterans Affairs healthcare system.  J Pharm Pract.  2017;3 0:180-4.
  • Watkins A, McKee J, Hughes C, et al. Community pharmacists’ attitudes toward providing care and services to patients with severe and persistent mental illness. J Am Pharm Assoc. 2017; 57(3S):S217-24.
  • Yang S, Britt RB, Hashem MG, Brown JN. Outcomes of pharmacy-led hepatitis C direct-acting antiviral utilization management at a Veterans Affairs medical center. J Manag Care Spec Pharm. 2017; 23:364-9.

Select Professional Posters: 

2021

  • Brown JN, Jennings A, McKnight AH, Durkee M. Effect of pharmacist interventions via a clinical dashboard on provider adherence to patient safety monitoring. Academy of Managed Care Pharmacy Nexus Meeting. October 2021.
  • Crowley MJ, Tarkington PE, Bosworth HB, Maciejewski ML, Steinhauser K, Jeffreys AS, Coffman C, Smith V, Danus S, Jeter DH, Majette Elliott N, Strawbridge E, Wilmot TC, Tisdale GA, Marcano T, Overby DL, Durkee MA, Bullard S, et al. Comparing two telehealth interventions for patients with clinic-refractory type 2 diabetes: A randomized controlled trial. American Diabetes Association Scientific Sessions Virtual Meeting. June 2021.
  • Hidlebaugh E, Sloane R, Pavon J, Mistry V, Morizio P, Pepin M, Bryan W, Johnson K, Colon-Emeric C. Racial disparities in psychoactive medication prescriptions in Veterans with falls risk. AGS Annual Meeting. Virtual Meeting. May 2021.
  • Mistry V, Morizio P, Bryan W, Bailey J, Hidlebaugh E, Pavon J, Colon-Emeric C, Pepin M. Fall-related medication deprescribing in older Veterans with mental health and chronic pain diagnoses. AGS Annual Meeting. Virtual Meeting. May 2021.
  • Morizio P, Mistry V, Pepin M, Bryan W, Devita M. Evaluation of psychoactive medications in Veterans admitted for elective surgery in the Perioperative Optimization of Senior Health (POSH) program. AGS Annual Meeting. Virtual Meeting. May 2021.
  • Shmuel S, Pate V, Pepin M, Bailey J, et al. Use of medications with anticholinergic and sedative properties and fall-related fractures among older adults. International Society for Pharmacoepidemiology Annual Meeting. August 2021.

2020

  • Bailey A, Hairston A, Bryan W, Hammond JM.  Adherence and safety of ibrutinib use in a Veteran population. Hematology/Oncology Pharmacists Association Annual Meeting – Tampa, FL. March 2020.
  • Brown JN, Jennings A. Influence of electronic ordering on medication errors in an investigational drug service. ACCP Virtual Annual Meeting. October 2020.
  • Cook H, Garris L, Gulum A, Steber C. Impact of SMART goals on diabetes management in a pharmacist-led telehealth clinic. ASHP Virtual Midyear Clinical Meeting. December 2020.
  • Cook H, Pervitsky V, Hashem M, Britt RB, Britnell S, Kothari DJ. Assessment of pancrelipase utilization within a Veterans Affairs health care system. American College of Gastroenterology Virtual Annual Meeting. October 2020.
  • Cook H, Pervitsky V, Hashem M, Britt R, Britnell S, Kothari D. Assessment of pancrelipase utilization within a Veterans Affairs health care system. ACCP Virtual Poster Symposium.  May 2020.
  • Dong OM, Poonnen PJ, Winski D, Reed S, Vashistha V, Bates J, et al. Cost-effectiveness of genomic profiling in veterans with metastatic lung adenocarcinoma. Seminar presentation at the Duke Center for Applied Genomics and Precision Medicine Genomic Forum. May 2020
  • Dong OM, Roberts M, Wu RR, Reed SD, Volls CI, Chanfreau-coffinier C, Sperber N, Gavin KL, Bates J, et al. Association between provider perceptions and ordering of pharmacogenomic tests at Veterans Affairs pharmacogenomic testing for veterans (PHASER) program test sites. American Society of Human Genetics meeting. October 2020.
  • Dong OM, Roberts M, Wu, R, Reed S, Voils C, Chanfreau C, Sperber N, Gavin K, Bates J, et al. A formative evaluation plan for the Veterans Affairs pharmacogenomic testing for veterans (PHASER) program. Podium presentation at the National Human Genome Research Institute Research Training and Career Development Annual Virtual Meeting. March 2020.
  • Han J, Nance C, Britt RB, Shoff C, Hostler C, Townsend M. Difference in outcomes between patients receiving oral versus intravenous antibiotics for the treatment of osteomyelitis. ASHP Virtual Midyear Clinical Meeting. December 2020.
  • Hu AM, Pepin MJ, Hashem MG, Britt RB, Britnell SR, Bryan WE, Brown JN. Development of a specialty medication clinical dashboard to improve tumor necrosis factor-alpha inhibitor safety and adherence monitoring. ACCP Virtual Annual Meeting. October 2020.
  • Intrator O, Veazie P, Li J, D’Arcy D, Westgate S, Pepin M, Morey M. Gerofit decreases medication use among older veterans. Gerontological Society of America Annual Meeting. November 2020.
  • Jennings A, Brown JN, Britt RB, McNaughton L, Durkee M, Hashem MG. Economic impact of community care prescriptions at a Veterans Affairs health care system. ASHP Virtual Midyear Clinical Meeting. December 2020.
  • Madaras-Kelly K, Hruza H, Pontefract B, McKie R, Hostler C, Townsend M, et al. Update on improving outpatient antibiotic use through implementation and evaluation of core elements of outpatient stewardship. Society for Healthcare Epidemiology of America Meeting – Atlanta, GA. March 2020.
  • Mistry V, Morizio P, Bryan W, Bailey J, Pepin M. Fall-related medication deprescribing in older Veterans with mental health and chronic pain diagnoses. ASHP Virtual Midyear Clinical Meeting. December 2020.
  • Morizio P, Mistry V, Pepin M, Bryan W, Devita M. Outcomes of a Perioperative Outcomes on Senior Health (POSH) Initiative. ASHP Virtual Midyear Clinical Meeting. December 2020.
  • Poonnen PJ, Dong OM, Winski D, Reed S, Vashistha V, Bates J, et al. Cost-effectiveness of genomic profiling in veterans with metastatic lung adenocarcinoma. American Society of Clinical Oncology Scientific Program Virtual Meeting. May 2020. "Cancer Merit Award" Winner.
  • Rana K, Ibrahim S, Gilbertson M, Britnell SR. Comparison of the effectiveness of liraglutide vs. semaglutide in a veteran population. ASHP Virtual Midyear Clinical Meeting. December 2020.
  • Shmuel S, Pate V, Pepin M, Bailey J, et al. Anticholinergic and sedative drug load among Medicare beneficiaries. Society of Epidemiologic Research Annual Meeting. June 2020.
  • Stein JF, Kothapalli R, Hale J. Atrial fibrillation in Durham VA home based primary care patients and implementation of anticoagulation therapy guidelines. Society of General Internal Medicine Annual Meeting – Boston, MA. April 2020.
  • Tampis PC, Britt RB, Hammond JM, Miller CS, Bates JS. Evaluation of the Veterans Health Administration (VHA) National Precision Oncology Program (NPOP) impact on prior authorization adjudication of targeted anti-cancer agents. ASHP Virtual Midyear Clinical Meeting. December 2020. 
  • Tillman III F, Behrens A, Moyihan M, et al. Residents creating healthy and resilient group environments (ReCHARGE): impact of resident-driven resiliency interventions on resident wellness and burnout. Audience: pharmacists, pharmacy students, pharmacy residents, pharmacy technicians. ASHP Virtual Midyear Clinical Meeting. December 2020.
  • Westgate S, Li J, Veazie P, Pepin M, et al. Gerofit decreases medication use among older veterans. AcademyHealth Annual Research Meeting – Virtual. August 2020.

2019

  • Bailey AG, Bryan WE, Hairston A, Hammond JM. Adherence and safety of ibrutinib use in a Veteran population. ASHP Midyear Clinical Meeting – Las Vegas, NV. December 2019.
  • Borlagdan J, Stump SE, Bates J, et al. Comparison of thromboembolic event rates with varying thromboprophylactic strategies in patients with multiple myeloma receiving lenalidomide. Poster awarded top 10 status nationwide.  Hematology/Oncology Pharmacists Association Annual Meeting – Fort Worth, TX. April 2019.
  • Britnell S, Burns J, Gilbertson M, Ibrahim S, Kemp D, Legge J, Parker M, Ottman A, Watkins A, Bullard S.  Pharmacist population health outcomes after nurturing engagement for diabetes: the PHONE-D intervention.  ACCP Virtual Poster Symposium. May 2019.
  • Compton ALP, Brown JN, Pepin M, Katzenberger D, Kemp DW. Success rate of statin rechallenge after the initiation of vitamin D supplementation in statin intolerant patients.  ACCP Annual Meeting – New York, NY. October 2019.
  • Compton ALP, Hewitt J, Garris L, Gold W. Implementation analysis of clinical pharmacy video telehealth services for veterans receiving home-based primary care. ASHP Midyear Clinical Meeting – Las Vegas, NV. December 2019.
  • Cook HE, Hewitt JH, Patterson EP, Randolph AE. Impact of drug interactions on major bleed rates in patients taking direct oral anticoagulants. ASHP Midyear Clinical Meeting – Las Vegas, NV. December 2019.
  • Hu AM, Pepin MJ, Hashem MG, Britt RB, Britnell SR, Bryan WE, Brown JN. Development of a specialty medication clinical dashboard to improve tumor necrosis factor-alpha inhibitor safety and adherence monitoring. ASHP Midyear Clinical Meeting – Las Vegas, NV. December 2019.
  • Johnbull E, Pepin M, Bryan W, et al. Relationship between neighborhood disadvantage and coronary artery bypass surgery outcomes in a national Veterans Affairs cohort. Society of Cardiovascular Anesthesiologists Annual Meeting & Workshops – Chicago, IL. May 2019.
  • Karamchandani D, Pyati S, Krishnamoorthy V, Bryan W, Pepin M, et al. Persistent post-intensive care opioid use in US veterans after major abdominal surgery. International Symposium on Intensive Care and Emergency Medicine – Brussels, Belgium. March 2019.
  • Lee TH, Chan A, Bryan W, Park L, Hashem M, Townsend M, Wang L, Moylan C, Britt R, et al. Usage of PPI reduces the SVR rate for HIV-HCV coinfected patients using ledipasvir/sofosbuvir: a real-world study from multicenter VA cohort. Digestive Disease Week Annual Conference – San Diego, CA. May 2019.
  • McKnight A, Smith K, Bryan WE, McDonald S, Lagoo-Deenadayalan S, Heflin M, Pepin M. Preoperative medication interventions in the perioperative optimization of senior health (POSH) initiative. ASHP Midyear Clinical Meeting – Las Vegas, NV. December 2019.
  • Moore S, Ohnuma T, Raghunathan K, Whittle J, Bartz RR, Pyati S, Ellis A, Bryan WE, Pepin M, et al. Preoperative gabapentinoids increase risk of postoperative opioid-related respiratory depression in adult patients undergoing total hip and knee arthroplasties. International Anesthesia Research Society Annual Meeting and International Science Symposium – Montreal, Canada. May 2019.
  • Morey MC, Pepin M, Pearson MP, et al. Cardiovascular, diabetes, mental health, and opioid medication use reduced after 1-year in Gerofit. Gerontological Society of America Annual Scientific Meeting – Boston, MA. November 2018.
  • Morizio P, Ottman A, Britnell SR. Impact of national valsartan recalls on Veterans’ outcomes. ASHP Midyear Clinical Meeting – Las Vegas, NV. December 2019.
  • Ogunwale A, Adams A, Elias A, Bailey JK, Pepin M, et al. FAME program: falls assessment of medications in the elderly. American Geriatric Society Annual Meeting – Long Beach, CA. May 2019.
  • Ohnuma T, Raghunathan K, Ellis A, Whittle J, Pyati S, Bryan WE, Pepin M, et al. Effects of acetaminophen, NSAIDs, gabapentinoids and their combinations on the day of surgery in total hip and knee arthroplasties. International Anesthesia Research Society Annual Meeting and International Science Symposium – Montreal, Canada. May 2019.  
  • Ohnuma T, Raghunathan K, Moore S, Setoguchi S, Ellis A, Fuller M, Whittle J, Pyati S, Bryan W, Pepin M, et al. Dose-dependent effects of gabapentin and pregabalin on the day of surgery in total hip and knee arthroplasties. International Conference on Pharmacoepidemiology & Therapeutic Risk Management – Philadelphia, PA. August 2019.
  • Sebring E, Rudisill MA, Bates J, et al. An evaluation of the effect of pharmacist-led comprehensive chemotherapy consultation services on outpatient appointment adherence. Hematology/Oncology Pharmacists Association Annual Meeting – Fort Worth, TX. April 2019.
  • Smith K, Bryan WE, Townsend ML, Randolph A, Vanderman A, Woodard C, Brown JN. Effects of prophylactic oseltamivir on warfarin control.  ACCP Annual Meeting – New York, NY. October 2019.
  • Sneed GT, Bryan WE, Hairston A, Hammond JM. Use and toxicity of zoledronic acid for bone involvement in veterans with breast cancer, prostate cancer, and multiple myeloma. Hematology/Oncology Pharmacists Association Annual Meeting – Fort Worth, TX. April 2019.
  • Yan R, Ohnuma T, Krishnamoorthy V, Ellis A, Ray N, Hsia J, Pyati S, Stefan M, Bryan WE, Pepin M, et al. Gabapentinoids on the day of colorectal surgery are associated with adverse postoperative respiratory outcomes. International Anesthesia Research Society Annual Meeting and International Science Symposium – Montreal, Canada. May 2019.

2018

  • Brown JN, Jacob S, Tillman III F, Britnell SR. Economic outcomes associated with an investigational drug service within a Veterans Affairs health care system.  ACCP Annual Meeting – Seattle, WA. October 2018.
  • Brown JN, Gordon S, Jacob S, Tillman III F, Britnell SR. Value of post-graduate pharmacy resident involvement in an investigational drug service within a Veterans Affairs health care system.  ACCP Virtual Poster Symposium.  May 2018
  • Compton A, Brown JN, Pepin M, Katzenberger D, Kemp DW. Success rate of statin re-challenge after the initiation of vitamin D supplementation in statin intolerant patients.  ASHP Midyear Clinical Meeting – Anaheim, CA. December 2018.
  • Day J, Cass A, and Bates J. Assessment and implementation of the pharmacist-performed physical exam. ASHP Midyear Clinical Meeting – Anaheim, CA. December 2018.
  • Gordon S, Bryan WE, Hammond J. Use and toxicity of checkpoint inhibitors for solid tumor treatment in a veteran population. Hematology/Oncology Pharmacists Association Annual Meeting – Denver, CO. March 2018.
  • Jacob S, Britt RB, Hashem MG, Bryan WE, Hale JC, Brown JN. Pharmacoeconomic analysis of safety interventions by a pharmacist-adjudicated prior authorization consult service.  ACCP Annual Meeting – Seattle, WA. October 2018.
  • Kraitman N, Fredenrich J, DeLucca B. Fosfomycin utilization and outcomes in a large VA medical center over a decade. ID Week – San Francisco, CA. October 2018.
  • Lee S, Bryan WE, Hale JC, Brown JN. Effect of prior authorization drug requests on patient adherence within a Veterans Affairs health care system.  ASHP Midyear Clinical Meeting – Anaheim, CA. December 2018.
  • McKnight A, Britt RB, Townsend M, Hashem M, Naggie S. Outcomes of chronic hepatitis C treatment with direct-acting antivirals in patients with slow response to treatment. ASHP Midyear Clinical Meeting – Anaheim, CA. December 2018.
  • Ogunwale A, Adams A, Elias A, Bailey JK, Pepin M, et al. FAME program: falls assessment of medications in the elderly. ASHP Midyear Clinical Meeting – Anaheim, CA. December 2018.
  • Schepers A, Jones A, Bates J, et al. A comparison of response in the presence or absence of a delay in induction therapy with lenalidomide, bortezomib, and dexamethasone for multiple myeloma. Hematology/Oncology Pharmacists Association Annual Meeting – Denver, CO. March 2018.
  • Shore SN, Britnell SR, Brown JN. Risk of adverse events with long-term phenazopyridine use for radiation cystitis.  ACCP Annual Meeting – Seattle, WA. October 2018.
  • Smith K, Townsend ML, Vanderman A, Randolph A, Woodard C, Bryan WE, Brown JN. Impact of prophylactic oseltamivir on international normalized ratio (INR) in patients on stable warfarin therapy.  ASHP Midyear Clinical Meeting – Anaheim, CA. December 2018.
  • Sneed GT, Bryan WE, Hairston A, Hammond JM. Use and toxicity of zoledronic acid for bone involvement in veterans with breast cancer, prostate cancer, and multiple myeloma. ASHP Midyear Clinical Meeting – Anaheim, CA. December 2018.
  • Warner CB, Hewitt JH, Garris LA. Comparison of A1c reduction in veterans initiated on saxagliptin versus empagliflozin. ACCP Virtual Poster Symposium.  May 2018.

2017

  • Brown JN, Britnell SR, Yang S. Impact of trainees on provider acceptance of clinical recommendations from a formalized drug information service.  ASHP National Residency Preceptors Conference – Washington, DC.  August 2017.
  • Burns JC, Porter A, Greck B.  Identifying predominant risk factors of osteoporosis in younger males.  US Public Health Service Consortium – Chattanooga, TN. June 2017. 
  • Chillari K, Bryan WE, Shah R, Rothrock-Christian T, Hammond J.  Evaluation of VTE prophylaxis practices in multiple myeloma patients receiving a lenalidomide-based regimen at the Durham VA Health Care System.  Hematology/Oncology Pharmacists Association Annual Conference – Anaheim, CA. March 2017.
  • Gordon S, Bryan WE, Hammond J. Use and toxicity of checkpoint inhibitors for solid tumor treatment in a veteran population. ASHP Midyear Clinical Meeting – Orlando, FL. December 2017.
  • Hammond J, Kelley MJ, Cunningham F, Volpp BD, Lowy E, Beste LA, Bullard AJ, Heron BB, Geraci MC, Aytaman A, LaPlant KD, Britt RB, O’Leary MC, Turner MJ, Hunt CM.  Anti-CD20 antibody order checks and medication use evaluation tracker increase hepatitis B testing and antiviral treatment in VHA.  Association of VA Hematology/Oncology Conference – Denver, CO.  September 2017. 
  • Jacob S, Britt RB, Hashem MG, Bryan WE, Hale JC, Brown JN. Pharmacoeconomic analysis of pharmacy adjudicated prior authorization drug request safety reviews in a Veterans Affairs healthcare system.  ASHP Midyear Clinical Meeting – Orlando, FL. December 2017.
  • Jasmine Bullard A, Cunningham FE, Volpp BD, Lowy E, Beste LA, Heron BB, Geraci M, Hammond JM, et al. Anti-CD20 antibody order checks and medication use evaluation tracker (MUET) increase hepatitis B testing and antiviral treatment in VHA. Association of VA Hematology/Oncology Annual Conference – Denver, CO. September 2017.
  • Katzenberger D, Brenner M. Evaluation of a pharmacist-driven 24-hour ambulatory blood pressure monitoring clinic at a Veterans Affairs Medical Center. American College of Cardiology 66th Annual Scientific Session & Expo – Washington, DC. March 2017.
  • Laurent MR, Hashem M, Bryan WE, Britnell SR, Hale JC, Brown JN. Effect of tiered copayments on medication adherence and persistence to oral anti-hyperglycemic medications.  ASHP Midyear Clinical Meeting – Orlando, FL. December 2017.
  • Loy B, Bailey J, Moss J, Bryan W, Davagnino J, Twersky J, Pepin M. Assessment of pharmacist recommendations in the Caring for Older Adults and Caregivers at Home (COACH) program. ASCP Annual Meeting – Chicago, IL. November 2017.
  • Ottman A, Townsend M, Hashem M, Britt R. Impact of substance use disorder on rate of sustained virologic response in veterans with chronic hepatitis C treated with direct-acting antivirals. ASHP Midyear Clinical Meeting – Orlando, FL. December 2017.
  • Polascik B, Kuo M, Barbeito A, Bryan W, Pepin M, Belden C, Raghunathan K.  What are the characteristics of patients who want perioperative music therapy? American Urological Association Annual Meeting – San Francisco, CA.  May 2017. 
  • Shore SN, Britnell SR, Brown JN. Safety analysis of long-term phenazopyridine use for radiation cystitis in a veteran population.  ASHP Midyear Clinical Meeting – Orlando, FL. December 2017.
  • Tillman F, Killius M, Hashem M. Evaluation of prescribing patterns for high-dose proton pump inhibitors and associated impacts on safety and cost.  ASHP Midyear Clinical Meeting – Orlando, FL. December 2017.
  • Warner CB, Hewitt JH, Garris LA. Comparison of A1c reduction in veterans initiated on saxagliptin versus empagliflozin. ASHP Midyear Clinical Meeting – Orlando, FL. December 2017.

 

  1. You’ll get wonderful clinical training at Durham VA Medical Center! 
  2. Best of both worlds:  2.5 hours to the beach and 3 hours to the mountains 
  3. Home of the Carolina Hurricanes NHL team and Durham Bulls Triple-A baseball team 
  4. The weather is great and the people are really nice! 
  5. Ranks as a “Best Place to Live” on multiple lists: 
     
  • #2 Best Place to Live (US News & World Report, 7/21)
  • Best Cities to Start a Career (WalletHub, 5/21)
  • #3 Happiest Cities in America (Men’s Health, 1/21)
  • #3 Best City for Millennials to Relocate (INDYWeek 1/20)
  • #2 Among Top Cities for Quality of Life (Numbeo 1/20)
  • Best Places to Raise a Family on a Budget (The Motley Fool 2020)
  • Among the 10 Best Cities to Move to Right Now (Curbed 2020)
  • #2 Best Big Cities to Live In (Wallethob.com 7/19)
  • #2 Most Family-Friendly Cities (Homes.com 2/19)
  •  
  1. Home of the best college basketball teams in the nation! 
  2. The area is home to two million people 
  3. A great place for outdoor activities: biking, hiking, swimming, and boating 
  4. Plenty of cultural activities: concerts, theater, symphony, opera 
  5. Research Triangle Park 

Website to visit: http://durhamchamber.org

DVAHCs Clinical Pharmacy Team

Preceptors: Bottom (L to R) Radhika Kothapalli, Janine Bailey, Alicia Watkins, Susan Bullard, Rachel Britt, Sara Britnell, Alicia Hairston; Middle (L to R) Dan Katzenberger, Jill Bates, Melissa Durkee, Amy Randolph, Andreina Ottman, Jayme Spivey, Tracie Rothrock-Christian, Bill  Bryan; Top (L to R) Megan Gilbertson, Caleb Burns, Ryan Owenby, Debra Kemp, Marc Pepin, Mohamed Hashem, Brandon DeLuccca, Jon Hale, Mary Parker, Jamie Brown

Durham VA Pharmacy Clinical Team

Janine Bailey, PharmD, BCPS is a Clinical Pharmacy Specialist in Home Based Primary Care (HBPC) Program at the Durham VA Medical Center.  She received her Doctor of Pharmacy degree from the University at Buffalo in 2007. She then completed a PGY1 residency at the North Texas VAMC and a PGY2 geriatric residency at the Durham VAMC. After her geriatric residency, she practiced as an Internal Medicine Clinical Pharmacy Specialist on an Acute Care of the Elderly (ACE) unit at Christiana Care Health System in Newark, DE.  She then returned to the Durham VAMC practicing in the Community Living Center (CLC) for nine years prior to transitioning to HBPC.  Practice interests include geriatrics and deprescribing. 

Jill S. Bates, PharmD, MS, BCOP, FASHP is the national PHASER Pharmacy Program Manager for the Department of Veterans Affairs specializing in precision medicine. She is also Associate Professor of Clinical Education at the UNC Eshelman School of Pharmacy. Dr. Bates completed her Bachelor of Science at Eastern Illinois University, a Master of Science with concentration in biochemistry and biophysics at Northern Illinois University and her Doctor of Pharmacy at the University of Illinois at Chicago. She completed a post graduate year 1 (PGY1) pharmacy practice and PGY2 oncology pharmacy residency at Duke University Medical Center. Dr. Bates practiced at UNC Medical Center for 11 years serving the hematologic malignancy population in both the acute and ambulatory care environment prior to shifting focus on precision medicine. She has experience as a leader in clinical pharmacy practice, oncology pharmacy, and residency training. Dr. Bates has a passion for advancing pharmacy practice through education rooted in the belief that learning improves lives.

Sara R. Britnell, PharmD, BCPS is a Clinical Pharmacy Specialist in Formulary Management for the Durham VA Health Care System. She received her PharmD from the Auburn University Harrison School of Pharmacy. She then completed her PGY1 residency at the Durham VA Medical Center in Durham, NC. Dr. Britnell continued her post-graduate training as a PGY2 resident specializing in drug information at the Durham VA Medical Center in Durham, NC. In addition to formulary management, her interests include drug information, pain, and women’s health.

Rachel B. Britt, PharmD, BCPS is a Clinical Pharmacy Specialist in Formulary Management at the Durham VA Health Care System. She received her Doctor of Pharmacy degree from Campbell University College of Pharmacy and Health Sciences. She then completed her PGY1 Pharmacy Residency at FirstHealth Moore Regional Hospital, followed by a PGY2 Drug Information Residency at the Durham VA Health Care System. She subsequently accepted a position there as the Hepatology Clinical Pharmacy Specialist and has recently transitioned to Formulary Management. In addition to hepatology and formulary management, her practice interests include infectious diseases, gastroenterology, and drug information.

Jamie N. Brown, PharmD, FCCP, BCPS, BCACP is the PGY2 Medication-Use Safety and Policy Residency Program Director.  He received his Doctor of Pharmacy degree from Campbell University College of Pharmacy and Health Sciences and then completed an ASHP-accredited specialty residency in Drug Information with Campbell University.  After completion of his residency, Dr. Brown accepted a clinical position with the Durham VA Medical Center as the Manager of the Drug Information Center and Investigational Drug Service.  In addition, Dr. Brown is a Clinical Professor of Pharmacy Practice with Campbell University and precepts fourth-year PharmD candidates and PGY1 and PGY2 Residents in the Drug Information rotation.  In 2014, Dr. Brown was the recipient of the NCAP Distinguished Young Pharmacist Award and received the Hospital Practice Preceptor of the Year Award from the Campbell University College of Pharmacy and Health Sciences class of 2014. Dr. Brown is very active in ASHP, ACCP, and NCAP and is currently the Chair-Elect of ACCP’s Drug Information Practice and Research Network. Additionally, Dr. Brown was elected as a Fellow of ACCP in 2020.

William (Bill) Bryan III, PharmD, BCPS is a clinical pharmacy specialist in the Community Living Center/Geriatrics. He earned a Doctor of Pharmacy from the University of North Carolina at Chapel Hill. He then completed a pharmacy practice PGY1 and a health-system administration PGY2 residency at the Gainesville, Florida VAMC. After residency, Dr. Bryan practiced in acute and long-term care.  Dr. Bryan came to work at the Durham VAMC in formulary management for approximately 10 years prior to transition to Geriatrics and is active in resident learning for both PGY1 & PGY2 programs. Dr. Bryan is also a resource for clinical data mining and analysis.  Dr. Bryan’s professional interests include aging, bone health, post-operative care, regulatory affairs, pharmacoeconomics, pharmacoepidemiology, antimicrobial stewardship, medication safety, and mental health.

Susan Bullard, PharmD is the CPS supervisor for PACT/Anticoag/Pain.  She received her Doctor of Pharmacy from the University of Florida in 1992 and completed a Pharmacy Practice Residency at the VA Medical Center in Memphis, Tennessee the following year. After completion of her residency, Dr. Bullard accepted a clinical pharmacy specialist position at the Durham VA Medical Center. She established the Pharmacy Practice Residency Program in 1994 and was the first residency director along with establishing the PRIME Pharmacy disease state management clinic. Dr. Bullard currently works in the anticoagulation clinic and provides coverage for PACT medication management clinics. Her areas of interests are HTN, anticoagulation and medication management.

Jonas “Caleb” Burns, PharmD is a Clinical Pharmacy Specialist in PACT/HEDIS at the Durham VA Medical Center. He received his Doctor of Pharmacy from Wingate University School of Pharmacy and completed a PGY1 Residency at the Charles George VA Medical Center in Asheville, NC. Caleb joined Durham in the summer of 2017 working in the primary care setting where he provides medication management and population health services.

Brian Chatel, PharmD, BCNSP is a Clinical Pharmacy Specialist in Critical Care and Nutrition Support. He received his PharmD from University of Southern Nevada, Nevada College of Pharmacy, and completed a PGY1 residency at Charleston Area Medical Center with emphasis in Critical Care and Clinical Nutrition in Charleston, West Virginia. Dr. Chatel has developed a Clinical Nutrition Program at the community hospital level and assessed and updated nutrition practice at Saint Vincent Hospital in Erie, PA. Dr. Chatel currently is the pharmacist on the Nutrition Support Team and performs daily rounds in Critical Care at Durham VAMC.

Hannah Cook, PharmD, BCPS is a Clinical Pharmacy Specialist in Ambulatory Care. She received her Doctor of Pharmacy degree from the UNC Eshelman School of Pharmacy. She went on to complete her PGY1 Pharmacy Practice residency and PGY2 Ambulatory Care Pharmacy residency at the Durham VA Health Care System. Following completion of residency, she accepted a position as a Clinical Pharmacy Specialist in Primary Care at the Clayton Community Based Outpatient Clinic where she sees patients for a variety of disease states such as hypertension, diabetes, anticoagulation, hyperlipidemia, smoking cessation, COPD, hypothyroidism, and medication adherence.

Brandon DeLucca, PharmD, BCPS is a Clinical Pharmacy Specialist in Internal Medicine. He received his Doctor of Pharmacy degree from the University of Florida College of Pharmacy in 2017. From there, he completed his PGY1 pharmacy residency at the James A. Haley Veterans’ Hospital (JAHVH) in Tampa, FL. After residency, Brandon worked as an outpatient staff and anticoagulation pharmacist at JAHVH before joining the Durham VA in March 2019. His professional interests include infectious diseases, pain management, and geriatrics.

Melissa Durkee, PharmD, BCACP is the Associate Chief of Pharmacy for Clinical Services at the Durham VA Medical Center (Durham VAMC) and a Clinical Pharmacy Specialist in Women’s Health. She received her Bachelor of Science Degree from the Albany College of Pharmacy, Union University and her Doctor of Pharmacy degree from Campbell University. Dr. Durkee has experience in community pharmacy and completed an academia/geriatrics specialty residency prior to joining the Durham VAMC team in 2001. She is a graduate of the VA Executive Career Field class of 2008. She maintains a clinical practice in the women’s health primary care clinic and is actively involved with several local, regional and national VA committees and for the NC Association of Pharmacists. Areas of interest for Dr. Durkee include geriatrics, primary care, women’s health and practice management.

Megan E. Gilbertson, PharmD, BCPS is a Clinical Pharmacy Specialist in 1D Primary Care and Population Health Management at the Durham VA Health Care System. She received her Doctor of Pharmacy from Wayne State University in Detroit, MI in 2015. After she completed her PGY1 Pharmacy Residency at VA Ann Arbor Healthcare System in Ann Arbor, MI, she stayed to begin her career at VA Ann Arbor Healthcare System focusing on providing services for dialysis, mental health and emergency department.  She now works in primary care in Durham providing medication management services and population health management.

Alicia Hairston, PharmD, BCOP is a clinical pharmacy specialist in oncology at the Durham VAMC. She received her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill, completed a pharmacy practice residency at Central Arkansas VAMC, and a specialty residency in oncology at Methodist University Hospital in Memphis, TN.  Prior to starting at the Durham VAMC, she worked as an inpatient clinical pharmacist in hematology/oncology at Duke University Hospital.  Her areas of interest include hematology, oncology, supportive care, and pain management.

Jonathan (Jon) Hale, PharmD, BCPS is a Home Based Primary Care (HBPC) and Transitional Care (TLC) Clinical Pharmacy Specialist. Jon is an Army veteran and served for 9 years as a Field Artillery Officer prior to attending pharmacy school. He completed his Doctor of Pharmacy degree at the University of North Carolina at Chapel Hill. While a student at UNC, Jon was a VALOR pharmacy intern at the Durham VA Healthcare System, assigned to work with the formulary management team. Prior to coming to Durham, Jon completed a PGY1 pharmacy practice residency at the VA Tennessee Valley Healthcare System in Nashville and Murfreesboro, TN.

Julia Hammond, PharmD, BCOP is the PGY2 Oncology Residency Program Director.  She completed her BS and Doctor of Pharmacy degrees at the University of South Carolina and her Pharmacy Practice & Oncology Specialty Residencies at the West Virginia University Hospital in Morgantown WV. Prior to joining the Durham VAMC, Dr. Hammond practiced as an Oncology Clinical Specialist at Fletcher Allen Healthcare in Burlington VT and as the Oncology Clinical Manager at Duke University Hospital where she also served as PGY2 Oncology Residency Director.  Her areas of interest include hematology & oncology therapeutics, supportive care and pain management.

Mohamed G. Hashem, PharmD, BCPS is a Pharmacoeconomics Program Manager. He earned a Doctor of Pharmacy from the South Carolina College of Pharmacy (University of South Carolina at Columbia campus) in 2010. He then completed a managed care pharmacy practice PGY1 residency at Medco Health Solutions Inc. in Franklin Lakes, NJ. After residency, Dr. Hashem accepted a position at Medco Health Solutions as a Clinical Content and Coverage Appeals Manager. In April 2013, Dr. Hashem joined the Durham VAMC in formulary management and is active in resident learning for both PGY1 & PGY2 programs. Areas of interest for Dr. Hashem include pharmacoeconomics, hepatitis c, medication adherence, research, and pharmacogenomics.

Sarai Ibrahim, PharmD, MS, BCACP is a Primary Care Clinical Pharmacy Specialist at the Hillandale Road Outpatient Clinic. She obtained a BA in Communication Studies from the University of North Carolina at Chapel Hill.  She received her Doctor of Pharmacy and Masters in Clinical Research from Campbell University College of Pharmacy and Health Sciences. She then completed a pharmacy practice residency at the W.G. Hefner VAMC in Salisbury, North Carolina. Dr. Ibrahim is a part of the Patient Aligned Care Teams (PACT) within the clinic and her practice interests include diabetes, hypertension, and population management.

Christie Kahlon, PharmD, MBA, BCPP, BCGP is the Clinical Pharmacy Specialist in Mental Health at the Durham VA Health Care System. She earned her Doctor of Pharmacy from Wingate University in 2015. She then completed a general pharmacy practice PGY1 residency at the Iowa City Veterans Affairs Health Care System and a specialty residency in psychiatry at a combined residency with the Iowa City Veterans Affairs Health Care System and the University of Iowa. After residency, Dr. Kahlon accepted a position at the Iowa City Veterans Affairs Health Care System working both inpatient and outpatient mental health. She also was an adjunct professor for the University of Iowa College of Pharmacy and preceptor to both residents and pharmacy students. She was active in education for medical students and psychiatry residents at the University of Iowa as well. Dr. Kahlon joined the Durham VA in 2018 working in inpatient mental health. Areas of interest include schizophrenia, bipolar disorder, PTSD, and geriatrics.

Dan Katzenberger, PharmD, BCPS, BCCP is the Clinical Pharmacy Specialist in Cardiology in the Durham VA Health Care System and precepts the Cardiology/CICU elective rotation. He earned a B.S. in Biology from Viterbo University in La Crosse, WI and received his Doctor of Pharmacy degree from the University of Wisconsin-Madison. During pharmacy school he was a pharmacy VALOR intern at the Madison VA Medical Center, which led him to want to pursue additional training and a career in the VA system. He completed a PGY1 pharmacy practice residency at the Milwaukee VA Medical Center and then continued his training by completing a PGY2 Cardiology pharmacy residency at the Ann Arbor VA Medical Center. Following residency, Dan moved out of the Midwest for the first time and joined the Durham VA pharmacy team in 2017. In June 2021, Dan was the recipient of the Duke Internal Medicine Residency Program’s Outstanding Service Award for contributions made towards resident development. When he’s not at work you can probably find him on a hiking trail or somewhere else outdoors.

Debra W. Kemp, PharmD, BCPS, BCACP is the PGY1 Residency Program Director. She received her Doctor of Pharmacy from the University of North Carolina at Chapel Hill and completed a primary care specialty residency at UNC Hospitals in Chapel Hill, NC. Prior to this position, Dr. Kemp worked at Wake Forest University Baptist Medical Center as an outpatient clinical pharmacist within the cardiology division, and was then on faculty at the UNC Eshelman School of Pharmacy in a co-funded position with the VA. In 2014, Dr. Kemp transitioned her efforts to a full-time clinical pharmacist specialist position at the VA focused in the 1D/1F primary care clinic.  In addition, Dr. Kemp serves as the Chair of the Residency Advisory Committee and is a member of the Pharmacy Residency Research Advisory Committee.  Dr. Kemp was awarded the NCAP Distinguished Young Pharmacist Award in 2011, the 2013 Experiential Faculty Instructor of the Year for UNC, and NCAP Ambulatory Care Pharmacist of the Year in 2020. Her interest areas include management of diabetes, dyslipidemia, hypertension and PTSD.

Radhika Kothapalli, PharmD, BCACP is a Home Based Primary Care (HBPC) Clinical Pharmacist and HBPC/Specialty Clinical Pharmacy Specialist Supervisor. She earned a B.S. in Pharmacy in 1992 and a Doctor of Pharmacy degree in 1995, both at the University of North Carolina. She completed a Pharmacy Practice residency at Moses H. Cone Memorial Hospital (1993) and an Ambulatory Care specialty residency at the Iowa City VAMC (1997). Prior to coming to the Durham VAMC, she worked for 4 years as an Ambulatory Care Clinical Pharmacy Specialist at the Iowa City VAMC.

Jenny Legge, PharmD is a Primary Care Clinical Pharmacy Specialist at the Hillandale Road Outpatient Clinic. She graduated and received her Doctor of Pharmacy in 2004 from Ohio Northern University in Ada, Ohio. She completed a pharmacy practice residency and primary care specialty residency at the Veterans Affairs Medical Center in Huntington, West Virginia. After completing her primary care residency, she accepted a position with the Durham Veterans Affairs Medical Center at the Hillandale Road Outpatient Clinic. Dr. Legge currently operates a Medication Management Clinic, which focuses on, but not limited to, drug therapy in the areas of hypertension, diabetes, hyperlipidemia, smoking cessation, medication compliance and anticoagulation.  She also helped to establish shared medical appointments (group classes) for patients with diabetes and hypertension. 

Ashley McKnight, PharmD, BCPS, BCGP is the Clinical Pharmacy Specialist in Pulmonary at the Durham VA Health Care System. She earned her Doctor of Pharmacy degree and three-year graduate Rural Health Certificate from the University of North Carolina Eshelman School of Pharmacy in 2018. She completed her PGY1 residency at the Durham VA where she developed an interest in internal medicine and geriatrics. She stayed at the Durham VA to complete the PGY2 Geriatric pharmacy residency. Dr. McKnight began developing pulmonary clinical pharmacy services in July 2020. Her pulmonary areas of interest include airway disease, transitions of care,  and medication safety in interstitial lung disease.

Clayton B. Nance II, PharmD, BCPS, BCIDP, CACP is a Clinical Pharmacy Specialist in Surgery and Antimicrobial Stewardship.  He received his PharmD from Campbell University before accepting a staff pharmacist position at Vidant Medical Center in Greenville, NC. He then spent the past 4 years practicing as a clinical pharmacist covering surgical services, internal medicine, and antimicrobial stewardship at UNC Rex Hospital in Raleigh, NC while also completing certificate programs in antimicrobial stewardship, anticoagulation, and lipid management. Dr. Nance joined the Durham VA Medical Center in March 2020 and currently rounds with the general and vascular surgery teams as well as co-managing the OPAT service and assisting with inpatient antimicrobial stewardship.  In addition to surgical services, his interests include antimicrobial pharmacotherapy, management of drug-resistant infections, and anticoagulation.

Andreina A. Ottman, PharmD, BCGP, is a Clinical Pharmacy Specialist in Ambulatory Care. She received her Doctor of Pharmacy degree from Palm Beach Atlantic University in sunny West Palm Beach, Florida. She completed her PGY1 pharmacy residency and PGY2 Geriatrics residency at the Durham VAHCS and subsequently joined the ambulatory care service, practicing in the women’s health clinic. In addition to ambulatory care, her practice interests include geriatrics, internal medicine, and infectious disease.

Ryan K. Owenby, PharmD is a Clinical Pharmacy Specialist in Emergency Medicine. He earned a Doctor of Pharmacy degree from the UNC Eshelman School of Pharmacy in Chapel Hill, NC. He then completed a PGY1 residency at the Durham VA Medical Center. After residency, Dr. Owenby accepted a Clinical Staff Pharmacist position at WakeMed Health and Hospitals in Raleigh, NC. His primary area of practice was in the level 1 trauma emergency department, as well as the medical, surgical, and neurological ICU. In 2013, Dr. Owenby returned to the Durham VA to establish clinical pharmacy services within the emergency department. At the VA, Dr. Owenby continues to precept UNC Eshelman School of Pharmacy students and PGY1 residents during their emergency medicine elective rotation. Dr. Owenby has served as the co-chair for the national Emergency Department Subject Matter Expert committee through the Clinical Pharmacy Practice Office. His areas of interest include infectious disease, acute stroke management, toxicology, and improving medication safety in the emergency department.

Mary Parker, PharmD, FASHP, FCCP, BCPS, BCCP is a Clinical Pharmacy Specialist in Ambulatory Care and Clinic Coordinator for the 1D Primary Care Clinic. She completed her Doctor of Pharmacy degree at Campbell University School of Pharmacy, pharmacy practice residency at The Moses H. Cone Memorial Hospital, and specialty practice residency in Anticoagulation/Cardiology/Academia at Moses Cone Health System and Campbell University. She developed pharmacist-led clinics as Director, Cardiovascular Risk Reduction Services in a multi-specialty physician office practice affiliated with Moses Cone in Greensboro, NC from 2000 – 2011 prior to joining the Durham VA. She was recognized as Preceptor of the Year by UNC School of Pharmacy in 2005 and the Upsher-Smith Innovation in Pharmacy Award winner for NC in 2011. Dr. Parker precepts and mentors residents and Doctor of Pharmacy Candidates from UNC Eshelman School of Pharmacy and Campbell University School of Pharmacy and Health Sciences. She is active in national and state organizations: she is a past-president of the NC Association of Pharmacists (2013), has served ASHP and ACCP in a variety of roles, and has been designated as Fellow of ACCP in 2014 and Fellow of ASHP in 2015. She will begin service as Regent for the ACCP Board of Regents in Fall 2020. Dr. Parker’s research interests include process improvement for care delivery, arrhythmias, and heart failure.

Emily Patterson, PharmD, BCACP is a Clinical Pharmacy Specialist in Endocrinology at the Durham VA Health Care System. She received her Doctor of Pharmacy from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy. While a student at UNC, she was a VALOR pharmacy intern at the Durham VAMC from 2012-2013, working with the formulary management team. Dr. Patterson completed a PGY1 pharmacy practice residency at the Richard L. Roudebush VAMC in Indianapolis, IN and a PGY2 ambulatory care residency at Duke University Hospital in Durham, NC. After completion of her residencies, she joined the Durham VAMC at the Raleigh CBOC working in primary care and anticoagulation. In May 2020, she transitioned to her current role where she created clinical pharmacy specialist services in the endocrinology department. She works mainly with complex diabetes patients (many who are on continuous glucose monitors and/or on U500 insulin) and in the bone clinic.

Marc J. Pepin, PharmD, BCPS, BCGP is the PGY2 Geriatric Residency Program Director. He received his Doctor of Pharmacy degree from the University of Florida and completed a geriatric pharmacy practice residency at the North Florida/South Georgia VAMC. After residency, Dr. Pepin accepted a position in acute care medicine at the James A. Haley VAMC, where he then transitioned to acute care surgery. He served as a preceptor for fourth-year PharmD candidates and PGY1 residents on medicine/surgery rotations. In January 2014, Dr. Pepin accepted a position at the Durham VAMC as a Geriatric Clinical Pharmacy Specialist in the Community Living Center (CLC). He is a preceptor for PGY1 and PGY2 residents, and interests include geriatrics, deprescribing, surgery, and medication safety.

Amy Randolph, PharmD, BCACP is a Clinical Pharmacy Specialist at the Durham VAMC. She received her Doctor of Pharmacy from Northeastern University in Boston MA. She then completed a pharmacy residency at the Durham VAMC in Durham, North Carolina. Dr.  Randolph joined the Durham VA pharmacy team after residency and currently works primarily in the outpatient anticoagulation clinic managing patients on warfarin, low-molecular weight heparin, and the direct oral anticoagulants.  In addition to anticoagulation, her practice interests include hypertension and diabetes.

Tracie Rothrock-Christian, PharmD, BCPS is a Clinical Pharmacy Specialist in Internal Medicine at the Durham VAMC. She received her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill and then completed a pharmacy practice residency at Duke University Hospital. Immediately following her residency, she worked as the Emergency Department Clinical Pharmacist at Duke Hospital. Prior to her current position, she was employed as a Clinical Pharmacist in Internal Medicine at Duke University Hospital and a Clinical Assistant Professor at the University of North Carolina Eshelman School of Pharmacy. She also served as an Assistant Director of Pharmacy Education with the Duke Area Health Education Center. Dr. Rothrock-Christian serves as a preceptor for UNC Eshelman School of Pharmacy students.  She precepts PGY1 and PGY2 residents in Internal Medicine and serves as the Inpatient Coordinator for the PGY1 residency program.

Randy Seys, PharmD, MS, BCGP, GCPP, CPE is a Clinical Pharmacy Specialist in Pain Management at the Durham VA Health Care System as well as an Adjunct Assistant Professor for the Division of Pharmacy Practice and Experiential Education at the University of North Carolina College of Pharmacy. He received his Doctor of Pharmacy degree from the University of Illinois College of Pharmacy in Chicago, Illinois.  He served in both the Air Force and Air National Guard and then continued in the uniformed services until retiring from the US Public Health Service Commissioned Corps in 2018.  During his time with the US PHS, he served in both the Indian Health Service and the Federal Bureau of Prisons (BOP).  While attached to the BOP, he developed the agency’s first PGY1 residency program and pharmacy-based pain management clinic.  He is board certified in geriatrics and is a certified pain educator (ASPE) as well as a general credential pain practitioner (AIPM).  

Kristin Smith, PharmD, BCPS is a Clinical Pharmacy Specialist in Ambulatory Care. She received her Doctor of Pharmacy degree from the UNC Eshelman School of Pharmacy. She completed her PGY1 Pharmacy Practice residency and PGY2 Geriatrics residency at the Durham VA Health Care System. She is now practicing in ambulatory care at the 1D Primary Care Clinic at the Durham VA where sees patients for a variety of disease states such as hypertension, diabetes, anticoagulation, hyperlipidemia, smoking cessation, COPD, hypothyroidism, and medication adherence. Her main area of interests include geriatrics, cardiology, and diabetes.

Jayme Spivey, PharmD, MS, BCPS is a Clinical Pharmacy Specialist at the Durham VA Medical Center.  She received her Doctor of Pharmacy degree and Master of Science in Clinical Research degree in 2012 from Campbell University in Buies Creek, NC.  She completed a PGY1 pharmacy residency in 2013 at the Gulf Coast Veterans Health Care System in the Joint Ambulatory Care Clinic located in Pensacola, FL.  She worked several years at the James H. Quillen VA Medical Center in Mountain Home, TN in the anticoagulation clinic and primary care settings prior to joining the anticoagulation clinic service at the Durham VA Medical Center.

Frank Tillman III, PharmD, BCPS is a Clinical Pharmacy Specialist in Academic Detailing and Mental Health/Substance Use Disorders. He received his Doctor of Pharmacy degree of the UNC Eshelman School of Pharmacy in 2019 and then completed a PGY1 Acute Care pharmacy residency followed by a PGY2 in Psychiatry at UNC Medical Center. His professional areas of interest include severe and persistent mental health, substance use disorders, health and workplace equity, and professional wellbeing. As a previous VALOR Intern in 2017, Dr. Tillman is extremely excited to be able to impact veteran health outcomes.

Mary L. Townsend, PharmD, AAHIVP is a Clinical Pharmacy Specialist in Infectious Diseases and Inpatient/Specialty Clinical Pharmacy Specialist Supervisor at the Durham VA Health Care System and an Adjunct Associate Professor in Infectious Diseases (Department of Medicine) as Duke University Medical Center, Durham, NC.  She received her Doctor of Pharmacy degree from Mercer University College of Pharmacy and Health Sciences in Atlanta, Georgia. She then completed a pharmacy practice residency at Duke University Hospital and a specialty residency in Internal Medicine/Infectious Diseases/Academia with Campbell University College of Pharmacy and Health Sciences at Duke University Hospital in Durham, NC. Prior to coming to the Durham VAHCS, she worked for two years as a Clinical Assistant Professor at the University of North Carolina Eshelman School of Pharmacy and was the Assistant Director of the Duke Area Health Education Center at Duke University Hospital. Dr. Townsend has been at the Durham VAHCS since 2003 and previously was an Associate Professor at Campbell University College of Pharmacy and Health Sciences for twelve years and the Co-Director of the Duke/Campbell Internal Medicine/Infectious Diseases/Academia Residency Program prior to her current clinical position. She was recognized as Professor of the Year at Campbell University School of Pharmacy in 2013. Dr. Townsend precepts residents on infectious diseases rotation, is the Co-Director of the Antibiotic Stewardship Program at the Durham VAHCS, Co-chair of the National Antimicrobial Stewardship CPPO Subject Matter Expert Work Group and was previously Chair of the Stewardship Committee of the Society of Infectious Diseases Pharmacists.  Her areas of interest include HIV, pharmacokinetics/pharmacodynamics of antimicrobial agents, and Antibiotic Stewardship.

Adam Vanderman, PharmD, BCPS is a Clinical Pharmacy Specialist at the Durham VA Medical Center. He received his Doctor of Pharmacy degree from the UNC Eshelman School of Pharmacy in Chapel Hill, NC in 2012. He completed his PGY1 pharmacy residency and PGY2 geriatrics residency at the Durham VA Medical Center and subsequently joined the anticoagulation service, practicing in the outpatient setting. In addition to anticoagulation, his practice interests include geriatrics and respiratory medicine.

Alicia Watkins, PharmD, BCGP is a Clinical Pharmacy Specialist in ambulatory care. She received her Doctor of Pharmacy degree from the University of Utah College of Pharmacy in Salt Lake City, UT. She then completed her PGY1 Pharmacy Practice Residency at UNC Eshelman School of Pharmacy and Community Care of North Carolina followed by a PGY2 residency in geriatrics at the Durham VA Health Care System. Following the completion of her PGY2 residency, she accepted a position as clinical pharmacy specialist in the PRIME primary care clinic at the Durham VA where she sees patients for a variety of disease states including, but not limited to, diabetes, hypertension, hyperlipidemia, smoking cessation, hypothyroidism, and medication adherence. Her areas of interest include geriatrics and diabetes.

Catherine Woodard, PharmD, BCACP is a Clinical Pharmacy Specialist at the Durham VA Medical Center. She received her BS in Pharmacy from the University of North Carolina in Chapel Hill, NC and her Doctor of Pharmacy from Campbell University in Buies Creek, NC. She completed a primary care residency at Mission Hospitals in Asheville, NC. Prior to starting at the Durham VA Medical center, she worked at Kaiser Permanente in Atlanta, GA as a clinical pharmacy specialist in primary care and as an assistant professor for Campbell University. Dr. Woodard has established a drug information service at the Durham VA, as well as a pharmacy run hyperlipidemia service and a pharmacy run hepatitis C clinic.  Currently, Dr. Woodard serves as the anticoagulation program director for the Durham VA Medical Center.

DVAHCS Preceptors

Raleigh CBOC Preceptors: (L to R) Emily Peedin, Carrie Thomas, Lindsay Garris, Brianna Glynn-Servedio, Alev Gulum, Jennie Hewitt, and Carolyn Steber

Lindsay Garris, PharmD, BCPS, BCACP is the PGY2 Ambulatory Care Pharmacy Residency Program Director. She received her Doctor of Pharmacy degree from the Arnold & Marie Schwartz College of Pharmacy at Long Island University—Brooklyn Campus. She then completed her Pharmacy Practice and PGY2 Ambulatory Care Pharmacy Residencies at the VA Maryland Health Care System (VAMHCS). Upon completion of her residency training, she was hired as a Clinical Pharmacy Specialist at VAMHCS where she established clinical pharmacy services in the Early Renal Insufficiency Clinic and provided direct patient care in the Heart Failure, Pharmacotherapy, Anticoagulation, and Erythropoietin Clinics. Since joining the Raleigh III Community-Based Outpatient Clinic (CBOC) team, she has expanded existing clinical pharmacy services in medication management and anticoagulation monitoring and partnered with Primary Care-Mental Health Integration to provide shared medical appointments for chronic pain management. She is a preceptor for the UNC Eshelman School of Pharmacy. She is involved with VA pharmacy residency training both locally and nationally as the VA Pharmacy Residency Coordinator, Federal Residents Council advisor, and VA Pharmacy Residency Advisory Board member.

Brianna Glynn-Servedio, PharmD, BCACP is a Clinical Pharmacy Specialist at the Raleigh 1 Community Based Outpatient Clinic. She received her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy. She completed a PGY1 and PGY2 residency in Ambulatory Care at the William S. Middleton Memorial Veterans Hospital (Madison VA) in Madison, WI. She now works in primary care in Raleigh providing medication management and anticoagulation services. Her main interests include diabetes, resistant hypertension, COPD, and geriatrics. Dr. Glynn-Servedio is also a member of the Pharmacy Research Advisory Committee.

Alev Gulum, PharmD, BCPS is a Clinical Pharmacy Specialist at the Raleigh Community-Based Outpatient Clinic (RCBOC). She received her Doctor of Pharmacy degree from the University of Rhode Island (URI) College of Pharmacy.  While studying at URI, she worked as a VALOR intern for the VISN 3 PBM and focused predominantly on formulary management. Dr. Gulum went on to complete her PGY-1 Residency and PGY-2 Ambulatory Care Pharmacy Residency at the VA Tennessee Valley Healthcare System in Nashville and Murfreesboro, TN.  She now works in primary care providing medication management and anticoagulation services in Raleigh.  Her other areas of interest include geriatrics, chronic pain management, research, and formulary management.

Jennie Hewitt, PharmD, BCACP is a Clinical Pharmacy Specialist at the Raleigh 3 Community- Based Outpatient Clinic (RCBOC). She received her Doctor of Pharmacy from Campbell University College of Pharmacy and Health Sciences. She then completed a pharmacy practice residency at the W.G. Hefner VAMC in Salisbury, North Carolina. Dr. Hewitt oversees the anticoagulation clinic at the RCBOCs including INR monitoring, lab monitoring of direct-acting oral anticoagulants, low molecular weight heparin monitoring, anticoagulation related consults as well as quality assurance for the Raleigh anticoagulation clinic. She is also involved in Patient Aligned Care Teams (PACT) where she is involved in the management of diabetes, dyslipidemia, and hypertension in medication management clinics.

Paige Morizio, PharmD, BCPS is a Clinical Pharmacy Specialist in Home Based Primary Care (HBPC) Program at the Clayton-East Raleigh Clinic.  She received her Doctor of Pharmacy degree from the University of North Carolina at Chapel Hill in 2019. She then completed a PGY1 pharmacy practice residency and a PGY2 geriatric pharmacy residency at the Durham VAHCS. After completion of her geriatric residency, she began her role in HBPC at the Durham VAHCS.  Her practice interests include geriatrics, polypharmacy, and deprescribing.

Carolyn Steber, PharmD, CDCES is a Clinical Pharmacy Specialist (CPS) at the Raleigh 1 Community Based Outpatient Clinic (CBOC). She received her Doctor of Pharmacy from Wingate University School of Pharmacy. Dr. Steber completed a pharmacy practice residency at the WG (Bill) Hefner VA in Salisbury, NC. She then completed a second year of residency at Wingate University School of Pharmacy where she specialized in ambulatory care. After residency, she started her career as a CPS with the Durham VAHCS at the Greenville Healthcare Center. In 2015, she transferred to the Raleigh 1 CBOC where she continues to serve as the CPS for several Patient Aligned Care Teams (PACT) providing medication management and anticoagulation services.  Dr. Steber also leads the diabetes and hypertension shared medical appointments (SMAs) at the Raleigh 1 clinic.

Carrie Thomas, PharmD, BCACP is the Clinical Pharmacy Supervisor for the Raleigh and Clayton Community Based Outpatient Clinics (CBOCs). She received her Doctor of Pharmacy from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy in 1999. She then completed a PGY1 Pharmacy Practice Residency at the University of Virginia Health System and a PGY2 Primary Care Specialty Residency at VCU Health System-Medical College of Virginia Hospitals & Physicians in Richmond, VA. Prior to coming to the Durham VAMC in 2007, she worked for six years at Grady Health System and served as program director for the Primary Care Specialty Residency and was a Clinical Pharmacist Specialist in Primary Care. Dr. Thomas established CPS-run disease management clinics at the Raleigh CBOC and has aided in the expansion of clinical services from 1 to 8 CPS spread across 3 sites of care.  Her areas of interest include diabetes, hypertension, dyslipidemia, and research on ambulatory care CPS

GHCC Preceptors

Greenville Health Care Center Preceptors: Left to right: Emily Heritage, Jillaine (Jill) Hardee, Emily Koenig, Sara Carlisle, Heather Coleman

Sara Carlisle, PharmD is a Clinical Pharmacy Specialist at the Greenville VA HCC in anticoagulation. Sara received her Doctor of Pharmacy in 2016 from Campbell University. She then completed a PGY1 with an ambulatory care focus at the Fayetteville VAMC. After residency, Sara took a position in PACT/Anticoagulation at the Greenville VA in July of 2017. In 2019, Sara transitioned to her current role as the Anticoagulation Lead at the Greenville HCC.

Heather Coleman, PharmD, BCACP is a Clinical Pharmacy Specialist at the Greenville VA Health Care Center. She received her Doctor of Pharmacy degree from University of North Carolina (UNC) Eshelman School of Pharmacy in 2015. While a student at UNC, Heather was a VALOR pharmacy intern at the Durham VAMC from 2012-2014, working primarily with geriatric practitioners in the CLC and COACH programs. After graduation, she completed a PGY1 Ambulatory Care Residency at UNC Medical Center and Ambulatory Care Clinics. After residency, she accepted a position as a Clinical Pharmacy Specialist at the Greenville VA HCC working in the PACT and Anticoagulation clinics. As of August 2019, she transitioned to the Home Based Primary Care (HBPC) program in Greenville. Her main interests include geriatrics and chronic disease management in the primary care setting.

Natasha L. Edmondson, BS, PharmD, BCGP is a Clinical Pharmacy Specialist in PACT/Anticoagulation at the Greenville Healthcare Center in Greenville, North Carolina. She arrived at the Durham VA System in March 2020 after transferring from the Dallas Veteran Affairs Medical Center in Dallas, Texas.  Dr. Edmondson started her professional career with the Teaching Fellows program, of which the “best and brightest” were selected in the pivotal role of teaching.  She served as a Teaching Fellow at NC Central University in Durham NC, where she graduated summa cum laude, receiving a BS degree in Chemistry/Secondary Education with a minor in Spanish.  Dr. Edmondson taught middle/high school for several years in the Charlotte-Mecklenburg School system prior to starting pharmacy school at Howard University in Washington DC. Graduating in 2007, Dr. Edmondson was awarded the DC Pharmacy Recognition award, bestowed upon the student demonstrating a strong commitment for pharmaceutical service to the DC community.  Upon completion of her PharmD, Dr. Edmondson completed an ASHP accredited PGY1 at Virginia Commonwealth University (VCU) in Richmond Virginia.  There she focused on community care to indigent populations, as well as traditional ambulatory pharmacy.  Dr. Edmondson is a Board Certified Geriatric Pharmacist (BCGP) with interests that include geriatric pharmacy, patient safety, and pharmacy policy.

Brooke Espenschied, PharmD is a Clinical Pharmacy Specialist at the Greenville VA Health Care Center. Brooke received her Doctor of Pharmacy from Ohio Northern University.  Upon graduation, she completed her PGY1 residency specializing in ambulatory care at the VA Central Ohio Healthcare System in Columbus. After completing her residency, Brooke joined the Greenville VA where she currently works as a PACT Clinical Pharmacy Specialist.

Emily Heritage, PharmD, BCACP is the Clinical Pharmacy Supervisor at the Greenville VA Health Care Center (GHCC). She received her Doctor of Pharmacy from the University of North Carolina at Chapel Hill. She then completed a pharmacy practice residency at the Durham VAMC. Dr. Heritage has established disease management, anticoagulation clinics and a diabetes shared medical appointment at the GHCC. Her main areas of focus are hyperlipidemia, hypertension, and diabetes. She also serves as a preceptor for the University of North Carolina Eshelman School of Pharmacy.

Emily Koenig, PharmD, BCACP is a Clinical Pharmacy Specialist at the Greenville VA HCC in PACT and anticoagulation. Emily received her Doctor of Pharmacy in 2010 from the University of Kentucky, College of Pharmacy. She then completed a PGY1 with a focus in ambulatory care and anticoagulation at the Boston VAMC in 2011. After completing her residency in Boston, she began working as a PACT Clinical Pharmacy Specialist at the Binghamton, NY CBOC (part of the Syracuse VAMC). In 2012 she became a board certified ambulatory care pharmacist. In March of 2015 she took her current position at the Greenville VA HCC.

 

Morehead Preceptors

Morehead City CBOC Preceptors: Left to right: Elizabeth (Beth) Flippin, Leslie Kriger

Leslie Kriger, PharmD, BCACP is a Clinical Pharmacy Specialist at the Morehead City VA Outpatient Clinic. She received her Doctor of Pharmacy from University of North Carolina-Chapel Hill Eshelman School of Pharmacy. She completed her PGY1 residency at the Durham VA Medical Center. Dr. Kriger is board certified in ambulatory care pharmacy (BCACP) and has been with the Durham VA HCS pharmacy team since her residency and practices as a PACT-anticoagulation clinical pharmacy specialist at the Morehead City VA clinic. In addition to her responsibilities managing Veterans on anticoagulation, Dr. Kriger established and maintains medication management clinics at the Morehead City VA clinic with focuses on chronic disease state management including diabetes, dyslipidemia, and hypertension.

 

Last updated: